Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2026 Jul 29;16:1740636. doi: 10.3389/fonc.2026.1740636

Therapeutic potential and mechanisms of rehabilitation interventions in preventing cancer metastasis

Xiaoyan Chen 1,2, Junfeng Zhang 2, Xiaoling Liu 2,3,*, Huijun Du 2,4,*
PMCID: PMC13463196  PMID: 42591922

Abstract

Cancer, a significant global public health challenge, has had a persistent increase in both incidence and mortality rates, with metastasis accounting for nearly 90% of cancer-related deaths worldwide. Consequently, the efficient prevention of cancer metastasis has emerged as a vital subject in contemporary medical research and clinical practice at the global level. This narrative review summarizes preclinical and clinical evidence on the role of rehabilitation interventions in preventing cancer metastasis, and highlights the importance of interdisciplinary teamwork in accomplishing this objective. Rehabilitation intervention includes diverse treatment modalities, such as exercise therapy, physical agent modalities, occupational therapy, and psychological intervention. These approaches substantially enhance patients’ quality of life while concurrently impeding the proliferation and metastasis of cancer cells by regulating the immune system, diminishing chronic inflammation, affecting the tumor microenvironment (TME), and adjusting hormonal levels in the body. This paper does a thorough investigation of the impact of rehabilitation interventions on diverse cancer patients, elucidating the distinct functions of different rehabilitation measures across cancer types to assess their effectiveness in preventing metastasis. This article examines the probable molecular mechanisms of rehabilitation intervention, elucidating the pathways by which it mitigates the risk of metastasis through the regulation of the immune system and the TME. Future research should prioritize well-designed randomized controlled trials (RCTs) with metastatic-related outcomes, integrate biological measures such as immune profiling, cytokine levels, and gene expression, emphasize patient-centered rehabilitation programs tailored to immune/tumor biomarkers and cancer types, and ensure long-term follow-up of over one year to assess sustained efficacy and survivorship outcomes.

Keywords: cancer metastasis, immune modulation, interdisciplinary teamwork, rehabilitation intervention, tumor microenvironment

1. Introduction

Cancer, a significant public health challenge globally, has shown a persistent increase in both incidence and fatality rates (1). According to the GLOBOCAN 2022 report, the number of new cancer cases worldwide has increased from approximately 10 million in 2000 to an estimated 20 million in 2022, reflecting a significant global rise (2). It not only presents a significant risk to human health but also has a substantial influence and considerable weight on global social and economic advancement. The economic burden is substantial, with global cancer care costs forecasted to exceed $500 billion by 2030, particularly driven by high-prevalence cancers such as breast, lung, and colorectal cancer (3). Cancer metastasis, the primary cause of cancer-related fatalities, has underscored the significance and immediacy of its prevention (4). Cancer metastasis is driven by a highly orchestrated and complex sequence of biological events collectively known as the metastatic cascade (5). This process initiates with the epithelial-mesenchymal transition (EMT), wherein primary tumor cells lose their cell-cell adhesion properties (such as the downregulation of E-cadherin) and acquire a migratory and invasive mesenchymal phenotype. Subsequently, these cells secrete matrix metalloproteinases (MMPs) to degrade the extracellular matrix and basement membrane, facilitating local invasion into the surrounding stroma. Following local invasion, tumor cells intravasate into the local microvasculature or lymphatic vessels. Once in the systemic circulation, circulating tumor cells (CTCs) face intense hemodynamic shear stress and immune surveillance, predominantly by natural killer (NK) cells. To survive, CTCs often associate with platelets to form tumor microemboli, effectively evading immune detection. Upon reaching distant microcapillary beds, these cells arrest, adhere to the endothelial lining, and undergo extravasation into the secondary organ parenchyma (6). Ultimately, the successful establishment of metastatic lesions requires the formation of a supportive pre-metastatic niche, metabolic adaptation, and secondary angiogenesis to sustain macroscopic growth (5) (Figure 1). This establishes a solid foundation for the role of rehabilitation interventions in avoiding cancer spread (7). Evidence suggests that exercise can modulate immune surveillance, reduce systemic inflammation, and alter the TME, while psychological interventions may lower chronic stress and associated pro-metastatic signaling (8). Rehabilitation intervention is essential in cancer management, incorporating exercise therapy, physical component treatment, and psychological intervention, aimed at enhancing patients’ quality of life (9). It also demonstrates potential in diminishing the danger of recurrence and metastasis. For example, a randomized controlled trial by Courneya et al. demonstrated that exercise interventions reduced recurrence and improved survival in breast cancer patients, while animal studies have shown that physical activity inhibits metastatic progression via immune-mediated pathways (10, 11). Due to the intricacy of cancer rehabilitation, an interdisciplinary approach is essential. This interdisciplinary intervention strategy enhances treatment outcomes and significantly improves patients’ quality of life and long-term prognosis (12). Research on the prevention of cancer metastasis is now advancing steadily, particularly in the area of rehabilitative intervention. Recent discoveries and technical advancements have revitalized active research in this domain, establishing a robust foundation for future inquiries and trajectories (13). A recent meta-analysis showed that regular physical activity is associated with a 27% reduction in cancer-specific mortality across multiple cancer (14). Moreover, structured rehabilitation programs have been linked to improved functional outcomes and survival rates in cancer patients (15).

Figure 1.

Illustration showing the metastatic process of cancer cells, including clonal expansion, invasion through the basement membrane and extracellular matrix, entry into blood vessels, interaction with lymphocytes and platelets, formation of emboli, and establishment and angiogenesis of metastatic tumors.

The main steps of the metastatic cascade. The process begins with clonal expansion and angiogenesis in the primary tumor. Metastatic subclones then invade the basement membrane and extracellular matrix to enter blood vessels. During circulation, tumor cells interact with platelets to form emboli, which helps them evade host lymphocytes. Finally, the surviving cells adhere to distant microvessels, exit the circulation, and establish metastatic foci fueled by secondary angiogenesis. Created by the authors using EdrawMax.

While prior research has concentrated on enhancing the overall health of cancer patients with rehabilitation therapy, the distinct roles of these interventions in inhibiting the metastatic process have not been comprehensively summarized and examined (13). For example, systematic reviews by Cormie et al. and Mishra et al. have demonstrated that exercise-based rehabilitation improves physical function and overall survival in cancer survivors. However, few studies have specifically addressed how these interventions may influence metastatic progression (15, 16). This review seeks to furnish scientific direction for oncology rehabilitation practitioners, patients, and their families by comprehensively synthesizing research findings on several rehabilitation modalities, thereby enhancing their participation in the rehabilitation process. In this context, participation refers to both improved adherence to rehabilitation protocols and greater patient empowerment in shared decision-making. These practical recommendations may offer novel pathways for advancing cancer rehabilitation and stimulate development in allied fields such as nursing, exercise therapy, physiotherapy, psychology, nutrition, and social work. The practical applicability of the rehabilitation intervention techniques examined in this paper is substantial in medical practice. These strategies may help decrease the risk of metastasis in cancer patients. For instance, observational studies have reported that regular exercise is associated with a 20-30% reduction in cancer recurrence in certain types of cancer (14). In addition, rehabilitation interventions have been shown to improve survival rates, enhance quality of life, and reduce psychological distress in cancer patients. For example, a meta-analysis reported that exercise-based rehabilitation resulted in significant improvements in both physical and mental health-related quality of life scores (15), and was associated with lower rates of depression and anxiety (17).

2. Literature search and selection process

This article is presented as a narrative review rather than a systematic review or meta-analysis. While narrative reviews do not strictly mandate adherence to systematic protocols such as PRISMA, we have proactively incorporated several PRISMA-inspired elements to enhance methodological transparency and reproducibility. We conducted a comprehensive literature search across four major databases: PubMed, Embase, Web of Science, and Scopus, retrieving articles published between January 2005 and June 2026. The search strategy utilized the following keywords and Boolean operators: (“cancer metastasis” OR “tumor metastasis”) AND (“rehabilitation” OR “exercise therapy” OR “physical therapy” OR “psychological intervention”).

The inclusion criteria were defined as follows: (1) original research articles or reviews investigating rehabilitation interventions in the context of cancer metastasis; (2) studies involving in vitro, in vivo, or human subjects; and (3) publications written in English. Conversely, the exclusion criteria comprised: (1) non-peer-reviewed articles (e.g., preprints, conference abstracts); (2) studies not directly relevant to rehabilitation or metastasis; and (3) case reports or small case series with fewer than 10 subjects. To ensure objectivity, two independent reviewers initially screened all titles and abstracts for eligibility, followed by a rigorous full-text review for final selection. Any discrepancies between the reviewers were resolved through thorough discussion; in instances where a consensus could not be reached, a third independent reviewer was consulted for final adjudication.

3. The mechanism of rehabilitation intervention

3.1. Mitigate chronic inflammation and augment immunological activity

Rehabilitation interventions, particularly physical activity, confer both direct and indirect effects on cancer patients as they relate to metastasis prevention. The direct physiological effects include the robust modulation of immune function, regulation of hormonal levels, and comprehensive remodeling of the TME (18). Specifically, recent evidence reveals that regular exercise stimulates muscle fibers to secrete myokines and extracellular vesicles, which subsequently downregulate collagen composition in the extracellular matrix and promote the intra-tumoral infiltration and activation of cytotoxic CD8+ T cells and NK cells (19, 20). These exercise-induced metabolic and immunological shifts actively suppress chronic inflammation and create a less permissive microenvironment for metastatic colonization (21). In addition to these direct pathways, physical activity exerts a profound range of indirect benefits, such as alleviating psychological distress, significantly reducing cancer-related fatigue, and enhancing patients’ overall adherence to rigorous treatment regimens (22). Collectively, these multi-target neuroendocrine and immunological regulations synergize to improve the overall prognosis and quality of life in patients at risk for metastasis.

Rehabilitation intervention has a multifaceted and synergistic purpose in avoiding tumor spread by augmenting immune function and diminishing chronic inflammation (23). Moderate rehabilitation exercises, including brisk walking, swimming, and yoga, markedly restore patients’ cardiopulmonary function and physical fitness while simultaneously bolstering the body’s anti-cancer capabilities through intricate immune regulatory processes (24). Specifically, aquatic exercises such as swimming enhance lung capacity and respiratory muscle strength due to the hydrostatic pressure and constant resistance provided by water, thereby improving overall cardiopulmonary endurance (25). Furthermore, mind-body interventions like yoga not only increase musculoskeletal flexibility but also significantly reduce systemic stress and circulating cortisol levels through regulated breathing and mindfulness practices, which is crucial for downregulating pro-tumorigenic inflammatory pathways (26). Both activities have been shown to reduce cancer-related fatigue and improve emotional well-being in survivors, thus positively contributing to the cancer recovery process (27, 28). Aerobic exercise can markedly augment the activity of NK cells and macrophages, hence enhancing their capacity to identify and eradicate cancer cells (29). NK cells are a crucial element of the innate immune system, and their augmented functionality directly influences the immune evasion capabilities of tumor cells (30). Aerobic exercise enhances NK cell function, facilitating the release of cytotoxic granules like perforin and granzyme, which induce death in tumor cells (29). Macrophages, pivotal cells within the tumor microenvironment (31), can be converted from M2 pro-tumor phenotypes to M1 anti-tumor phenotypes via the modulation of aerobic exercise, thereby augmenting their phagocytic capacity against tumor cells and promoting the secretion of anti-inflammatory cytokines such as IL-12, which diminishes pro-inflammatory responses in the TME and curtails the proliferation and metastasis of tumor cells (18).

Consistent physical activity modulates the hypothalamic-pituitary-adrenal (HPA) axis, mitigates stress reactions, and diminishes the release of stress hormones, including cortisol and adrenaline (32). The overproduction of stress hormones facilitates tumor proliferation and metastasis, mostly by stimulating pro-inflammatory pathways, including NF-κB and STAT3 signaling, thereby enhancing the synthesis of pro-inflammatory cytokines like TNF-α and IL-6 (33). Exercise can diminish the levels of pro-inflammatory factors, hence mitigating the influence of chronic inflammation on tumor metastasis (34). Aerobic exercise simultaneously enhances the production of anti-inflammatory cytokines, such as IL-10, which regulates immunological equilibrium, suppresses chronic low-grade inflammation inside the TME, and diminishes the proliferative capacity of cancer cells (35). Recent preclinical and clinical studies have clarified that exercise induces systemic increases in IL-6 and IL-15, which are crucial for NK cell proliferation and cytotoxic activation via the STAT5 pathway. In breast cancer models, exercise-induced IL-15 signaling enhances NK cell expression of NKG2D receptors, facilitating recognition and lysis of metastatic tumor cells (11, 36). Similarly, in colorectal cancer, catecholamine-mediated β-adrenergic receptor activation mobilizes NK cells to the circulation and metastatic niches, where they exert anti-metastatic effects by secreting IFN-γ and downregulating tumor-associated MMPs (37).

Moreover, frequent exercise significantly enhances the hypoxic condition of the TME (18). Hypoxic circumstances often facilitate the invasion and spread of tumor cells, whereas exercise enhances tissue oxygenation and improves local microcirculation, thus decreasing the expression of hypoxia-inducible factor (HIF-1α) (38)and decelerating tumor progression (Figure 2).

Figure 2.

Infographic illustrating how rehabilitation intervention, represented by a person using an exercise bike, can enhance immune function and reduce chronic inflammation via four mechanisms: activating NK cells, regulating macrophages, regulating the HPA axis, and improving the tumor microenvironment, each with corresponding changes in cellular activity, cytokines, and reduction in tumor invasion and metastasis.

Mechanistic pathways of rehabilitation interventions in mitigating cancer metastasis. Rehabilitation modalities primarily exert anti-metastatic effects through dual mechanisms: immune modulation and the attenuation of chronic inflammation. On the immune axis, interventions activate NK cells to upregulate perforin and granzyme expression, thereby promoting tumor cell apoptosis. Simultaneously, they induce macrophage polarization toward the anti-tumor M1 phenotype, enhancing IL-12 secretion and phagocytic capacity. Concurrently, on the inflammatory axis, rehabilitation regulates the HPA axis to inhibit pro-inflammatory cytokines while upregulating anti-inflammatory IL-10. This collectively improves the TME by increasing local oxygen supply and downregulating HIF-1α ultimately suppressing tumor invasion and metastasis. Created by the authors using EdrawMax.

3.2. Determinants influencing tumor biomarker expression

Targeted rehabilitation techniques, including exercise interventions, exert direct physiological effects by modulating hormone levels and cytokine expression, thereby directly influencing tumor growth and metastatic potential. Meanwhile, psychosocial support indirectly benefits patients by improving psychological well-being, which can further modulate stress pathways and support immune function (39). Specifically, these interventions may reduce circulating pro-tumorigenic factors such as insulin-like growth factor-1 (IGF-1) and inflammatory cytokines, while increasing anti-inflammatory mediators, thus creating a less favorable environment for tumor cell proliferation and dissemination. These therapies enhance patients’ physiological condition-such as improving immune surveillance and preserving or increasing skeletal muscle mass and function-and are essential in modulating the TME. Exercise intervention impacts the TME by modulating the endocrine system (18). Consistent rehabilitative exercises, like brisk walking, swimming, and yoga, can enhance the secretion of endorphins in the body (40). Endorphins, functioning as an endogenous analgesic and anti-stress agent, mitigate patients’ stress, alleviate pain, and enhance their general psychological well-being (41).

Moreover, elevated endorphin levels have been associated with improved immune function and reduced systemic inflammation, both of which are critical in supporting cancer therapy and rehabilitation (22). By mitigating cancer-related fatigue and enhancing mood, these neuroendocrine improvements may also contribute to better adherence to rigorous treatment protocols and potentially lower the risk of cancer recurrence. Furthermore, consistent exercise positively regulates metabolic adaptations and normalizes blood circulation within the TME, alleviating local hypoxia and thereby suppressing metastatic progression (18). Exercise enhances local blood circulation and tissue oxygenation, hence decreasing hypoxia levels in tumor tissues (42). Hypoxia is a significant characteristic of the TME, and can enhance the proliferation and metastatic potential of tumor cells by upregulating HIF-1α. HIF-α is a key transcription factor activated under low oxygen conditions, which promotes angiogenesis, metabolic adaptation, and the expression of genes that support tumor cell survival, proliferation, and metastasis. Exercise intervention can diminish HIF-1α expression by enhancing local tissue oxygenation, thereby reducing tumor cell invasiveness (43). Research indicates that suitable exercise can modulate the expression of adhesion molecules on tumor cell surfaces, diminish the attachment capacity of tumor cells to the surrounding matrix, and inhibit their distant dissemination via the arterial or lymphatic systems (44).

Psychological intervention indirectly influences the TME by modulating patients’ psychological states (45). Chronic psychological stress can stimulate the HPA axis, resulting in the overproduction of stress hormones and the enhancement of pro-inflammatory responses (46). Specifically, chronic stress increases the secretion of cortisol and elevates levels of pro-inflammatory cytokines such as IL-6 and TNF-α. This creates a tumor-promoting microenvironment by suppressing anti-tumor immunity and facilitating tumor growth and progression (47, 48). Effective psychosocial assistance, including cognitive behavioral therapy, mindfulness therapy, and emotional support groups, can ease patients’ anxiety and despair, thereby reducing cortisol and adrenaline levels and diminishing the expression of stress-related biomarkers (49). This enhancement in psychological condition aids in diminishing the activation of pro-inflammatory signaling pathways, thereby regulating the endocrine system and suppressing the activity and spreading potential of tumor cells (50). Moreover, psychosocial support can augment patients’ positive psychological coping, enhance their general health status, and further facilitate the proper functioning of the immune system and the amelioration of the TME (51). These extensive rehabilitation interventions markedly diminish the likelihood of tumor proliferation and metastasis by modifying multiple facets of the TME, therefore enhancing patients’ long-term survival rates and quality of life (52) (Figure 3).

Figure 3.

Flowchart illustrating how psychosocial support leads to improved psychological state, which then regulates the HPA axis, immune system, signaling pathways, and anti-inflammatory factors, ultimately improving the tumor microenvironment by reducing hypoxia, tumor cell activity, pro-inflammatory response, and metastatic potential.

Psychophysiological pathways linking psychosocial interventions to the inhibition of cancer metastasis. Psychosocial support mitigates psychological distress translating these psychological improvements into systemic anti-tumor physiological responses. Central to this mechanism is the attenuation of the HPA axis, leading to reduced circulating levels of stress hormones such as cortisol and adrenaline. This neuroendocrine modulation directly suppresses pro-oncogenic intracellular signaling pathways, specifically NF-κB and STAT3, resulting in the downregulation of pro-inflammatory cytokines and the upregulation of anti-inflammatory mediators. Collectively, these systemic shifts enhance immune surveillance by boosting NK cell and macrophage activity. Consequently, this multi-target regulation ameliorates the TME by alleviating hypoxia and dampening local inflammatory responses, ultimately diminishing tumor cell viability and metastatic potential. Created by the authors using EdrawMax.

3.3. Regulation of hormonal concentrations in the body

Rehabilitation intervention modulates hormonal levels in the body via many pathways and is crucial in inhibiting tumor spread (53). The two primary components of rehabilitation intervention are psychological and social support, together with frequent rehabilitation exercises (54). By modulating stress hormones, sex hormones, and facilitating the production of beneficial neurotransmitters, it markedly enhances the physical and mental condition of patients, reinstates immunological function, and diminishes the likelihood of tumor spreading (55). The control of stress hormones constitutes a fundamental mechanism in rehabilitation interventions (18). The stress response is typically governed by the HPA axis, with cortisol being one of its ultimate products (56). Cortisol is a crucial hormone associated with stress (57). Prolonged excessive secretion can induce a range of detrimental effects on the immune system, including the suppression of immune cell proliferation and activity, as well as the enhancement of pro-inflammatory cytokine production, such as TNF-α and IL-6, which exacerbates the TME and facilitates the growth and metastasis of tumor cells (58).

Psychological and social interventions, including counseling, group therapy, and the creation of support networks, can substantially alleviate patients’ psychological stress (59). Psychological stress is the primary catalyst for increased cortisol release (60). These intervention approaches significantly ease patients’ anxiety and despair, restore balance to the hyperactive HPA axis, and normalize cortisol levels. Research indicates that prolonged elevated cortisol levels result in immunological suppression and intensify inflammatory responses by activating the NF-κB signaling pathway, which is a key regulator of inflammation, so facilitating the survival and spread of tumor cells (61). Psychological intervention diminishes cortisol output and obstructs pro-inflammatory signaling pathways, thereby mitigating the influence of chronic inflammation on tumor spread (62). On the other hand, aerobic exercise and weight training stimulate the secretion of beneficial hormones in the body. Aerobic exercise and weight training stimulate the secretion of beneficial hormones in the body, including endorphins and serotonin (63). These beneficial hormones are essential for enhancing patients’ mental well-being. Endorphins, being natural painkillers produced within the body, provide analgesic and euphoric properties, successfully mitigating pain, enhancing mood, and decreasing discomfort associated with tumor therapy (64). The release of endorphins markedly elevates after consistent aerobic activities (such as jogging and swimming) and resistance training, aiding patients in managing psychological and physiological stress during therapy (65). Serotonin is a neurotransmitter integral to emotional regulation, significantly influencing mood and mitigating anxiety and sadness (66). Moderate exercise elevates the synthesis and release of serotonin, hence increasing patients’ mood and indirectly strengthening immune surveillance performance. The elevation of serotonin diminishes the activity of the HPA axis and lowers cortisol release, thereby alleviating the inhibitory impact on the immune system (67).

Furthermore, rehabilitative exercise is crucial for sustaining the equilibrium of sex hormones, particularly in regulating testosterone and estrogen levels (68). These hormones not only play crucial roles in reproductive activities but also exert major influence on immune system control (69). An excessive imbalance of testosterone and estrogen, particularly during tumor therapy, might adversely affect the immune system by suppressing T cell and B cell activities, thereby diminishing immunological surveillance (70, 71). Research indicates that modest rehabilitative exercise can sustain the equilibrium of sex hormone levels in the body (72). For instance, weight training can elevate testosterone release, which not only improves muscle strength and physical fitness but also augments NK cell activity through its immunological regulatory impact, facilitating their detection and destruction of tumor cells (73). Moreover, consistent aerobic activity might positively influence estrogen metabolism by decreasing body fat percentage and mitigating excessive estrogen accumulation in the body (74). Elevated estrogen levels may facilitate the development of specific malignancies, including breast cancer (75). Consequently, rehabilitation exercises may indirectly impede the advancement and metastasis of malignant malignancies by regulating estrogen levels.

Rehabilitation intervention offers patients an improved endocrine milieu by modulating several hormones, including cortisol, endorphins, serotonin, and sex hormones, therefore reinstating and augmenting immune system functionality. The management of hormone levels efficiently inhibits tumor spread by enhancing the TME, suppressing pro-inflammatory pathways, and facilitating the generation of anti-inflammatory cytokines (Figure 4).

Figure 4.

Illustration showing a person engaging in rehabilitation intervention, with psychosocial support and regular rehabilitation exercise, linked to positive changes in brain, adrenal gland, and reproductive organ hormone regulation, including increased endorphins, serotonin, and testosterone, reduced cortisol and estrogen, enhanced immune function, lower anxiety and depression, reduced inflammation, and decreased tumor progression.

Systemic neuroendocrine and immune modulation driven by comprehensive rehabilitation interventions. The integration of psychosocial support and regular rehabilitation exercise orchestrates a systemic anti-tumor environment via the neuroendocrine-immune network. In the central nervous system, these interventions upregulate positive neuromodulators, which alleviates anxiety and depression while dampening the hyperactive HPA axis. This neuroendocrine shift reduces the secretion of stress hormones, particularly cortisol, thereby mitigating systemic inflammatory responses evidenced by the downregulation of pro-inflammatory cytokines and the upregulation of anti-inflammatory IL-10. Furthermore, the regulation of sex hormones synergizes with these processes to augment NK cell cytotoxicity. Collectively, this restoration of endocrine homeostasis and immune surveillance robustly inhibits tumor progression and metastatic dissemination. Created by the authors using EdrawMax.

4. Rehabilitation intervention strategies

4.1. Types of rehabilitation interventions

Rehabilitation interventions for cancer patients encompass diverse strategies aimed at improving physical function and overall health, while also affecting the TME, immune system, and anti-inflammatory mechanisms through multidimensional regulatory effects. Aerobic exercise and resistance training, as crucial elements of rehabilitation in exercise therapy, exhibit considerable anti-cancer efficacy (76). Aerobic exercise can efficiently modulate the immune system, specifically by augmenting the activity of T cells and NK cells, thus strengthening the body’s capacity to identify and eradicate tumor cells (77). Aerobic exercise enhances blood circulation and oxygen delivery, alleviating the effects of hypoxia in the TME and thereby diminishing the likelihood of tumor cell spread (78). Aerobic exercise can inhibit tumor-associated chronic inflammation and diminish the synthesis of pro-inflammatory cytokines (such as TNF-α and IL-6), hence lowering the chance of cancer spread (79). Resistance exercise can impede the proliferation of cancer cells by enhancing muscular mass, strength, and metabolic function (80, 81). Resistance training can modulate metabolic pathways, improve mitochondrial function, and diminish the invasive capacity of tumor cells via aberrant energy metabolism (82). Exercise therapy enhances patients’ general physical fitness while significantly diminishing the chance of tumor dissemination and metastasis through the regulation of immune responses, anti-inflammatory mechanisms, and metabolic processes (83, 84). Customized exercise regimens in physical therapy can augment muscular strength, enhance joint functionality, and sustain functional mobility by mitigating pain and activity restrictions resulting from cancer metastasis, thereby contributing to the prevention of tumor dissemination (85). Rehabilitation interventions aimed at the lymphatic system, such as manual lymphatic drainage, are especially beneficial for breast cancer patients, markedly decreasing the incidence of lymphedema and diminishing the likelihood of cancer cell proliferation via the lymphatic system by facilitating lymphatic fluid return (86) (Table 1).

Table 1.

Structured exercise interventions in cancer rehabilitation.

Modality Frequency Intensity Time Type Outcomes Mechanisms
Aerobic (14) 3–5 times/week Moderate (40–60% VO2max or 3–6 METs) 20–45 min/session Walking, cycling, treadmill Cardiorespiratory fitness, fatigue, QoL, immune markers ↓Inflammation, ↑NK cell function
Resistance (87) 2–3 times/week Moderate (60–70% 1RM) 20–45 min/session Free weights, resistance bands Strength, muscle mass, function ↑Muscle protein synthesis, ↑Insulin sensitivity
Combined (88) 2–3 times/week Moderate 40–60 min/session Aerobic +resistance Combined above outcomes Synergistic effect: function, body composition
Flexibility/Stretching (89) 2–3 times/week To point of tightness 10–20 min/session Static or dynamic stretches Range of motion, pain, stiffness Maintains joint mobility, ↓musculoskeletal discomfort
Mind–body (Yoga,Tai Chi) (90) 1–3 times/week Low–moderate 30–60 min/session Yoga, Tai Chi, Qigong Anxiety, sleep, QoL, fatigue ↓Cortisol, ↑Vagal tone

Recent research has progressively demonstrated the synergistic effects of exercise treatment and physical factor intervention in suppressing tumor metastasis. During the acute postoperative phase, preclinical research indicates that high-intensity interval training (HIIT) can augment the tumor-eradicating capacity of CD8+ T cells by stimulating the secretion of myokines, such as IL-15, from muscle tissue (91). Myokines are cytokines or peptides released by muscle fibers during contraction, which can modulate immune cell activity. For example, IL-15 enhances the proliferation and cytotoxicity of CD8+ T cells and NK cells, thereby strengthening the body’s anti-tumor immune response (92). Concurrently, local hyperthermia has been demonstrated to elevate the expression of HSP70 on the surfaces of tumor cells, thereby improving the recognition efficacy of NK cells for circulating tumor cells (93). Clinical cohort studies suggest that the combination of the two can decrease the incidence of cancer metastases following cancer surgery (94). In patients with stable disease, moderate-intensity continuous training has been shown to diminish tumor-associated macrophage infiltration by inhibiting the HMGB1/TLR4 signaling pathway in breast cancer models (95), whereas transcutaneous electrical nerve stimulation (TENS) preserves NK cell activity by modulating the β-endorphin/μ-opioid receptor axis and alleviating pain-related stress responses (96). The amalgamation of the two markedly enhances the 1-year progression-free survival rate of patients with non-small cell lung carcinoma (97). In the long-term rehabilitation phase, the efficacy of resistance training in postponing cancer cachexia via the IGF-1/mTORC1 pathway has been corroborated by numerous randomized controlled trials (98). The insulin-like growth factor 1 (IGF-1)/mechanistic target of rapamycin complex 1 (mTORC1) pathway constitutes a central cellular signaling cascade governing skeletal muscle homeostasis. Activation of this axis robustly upregulates muscle protein synthesis and concurrently suppresses proteolytic pathways, thereby effectively inhibiting muscle wasting and mitigating cancer-related cachexia (18, 99). While the identification of whole-body vibration therapy as a means to impede YAP/TAZ nuclear translocation through the activation of the mechanically sensitive ion channel PIEZO1 presents a novel target for obstructing mechanically induced metastatic spread (100). YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif) are critical mechanosensitive transcriptional coactivators. In a pro-tumorigenic microenvironment, mechanical cues trigger YAP/TAZ to translocate into the cell nucleus, where they bind to transcription factors to drive the expression of target genes responsible for tumor cell proliferation, EMT, and metastasis. Impeding this nuclear translocation effectively sequesters YAP and TAZ in the cytoplasm, neutralizing their pro-metastatic signaling cascades (101). PIEZO1 is a mechanically sensitive ion channel found in cell membranes that responds to mechanical stimuli, and its activation can influence cell signaling and movement, thereby affecting the metastatic potential of tumor cells. Current evidence indicates that exercise intervention mostly influences systemic immune regulation, whereas physical factor therapy emphasizes the remodeling of the local microenvironment (18). The sequential integration of the two may yield a synergistic impact of “1 + 1>2”; nevertheless, the molecular docking mechanism and personalized dosing necessitate further investigation through interdisciplinary research (102).

Alongside exercise therapy and physical factor treatment, various rehabilitation treatments, as crucial elements of rehabilitation intervention, significantly contribute to the overall enhancement of patients’ quality of life and health status. Occupational therapy assists patients in adjusting to physical limitations and enhancing their capacity to execute daily activities, such as dressing, eating, and personal hygiene management (103). This, in turn, mitigates life stress and modulates the immune system by alleviating psychological burdens, which may inhibit cancer metastasis (104). Pain management, a crucial component of rehabilitation, particularly in physical therapies such as electrotherapy, cryotherapy, thermotherapy, and massage, enhances patient mobility by modulating the nervous system and alleviating chronic pain, diminishing the body’s stress response, and consequently inhibiting the proliferation and metastasis of tumor cells via stress-related mechanisms (105). Furthermore, the use of extensive rehabilitation strategies from traditional Chinese medicine, including acupuncture and herbal interventions, enhances the modalities of rehabilitation treatment (106). Acupuncture modulates the central nervous system and immunological response, alleviates pain, and enhances sleep quality (107). It may also impede metastatic factors in the TME by modulating the production of HPA axis and inflammatory mediators (108). Herbs such as Astragalus and Ganoderma lucidum exhibit substantial immune regulatory properties, augmenting macrophage and T cell capabilities, strengthening the body’s immune surveillance capacity, and diminishing the proliferation and metastasis of cancer cells (109). Long-term stress and negative emotions are significantly associated with cancer spread in the context of psychological and social support (110). Psychological interventions, including cognitive behavioral therapy (CBT) and mindfulness-based stress reduction (MBSR), can modulate patients’ psychological states and endocrine systems, mitigate the adverse effects of chronic stress on the TME, and effectively impede the proliferation and migration of tumor cells (111, 112). Consequently, rehabilitation interventions, utilizing multi-dimensional processes, exhibit extensive and significant effects in preventing tumor metastasis, thereby offering enhanced support and safeguarding the long-term health of cancer patients (Table 2).

Table 2.

Types of rehabilitation interventions and their mechanisms of action.

Intervention type Specific forms of intervention Main mechanism of action
Exercise therapy Aerobic exercises (jogging, swimming, brisk walking) Regulate immune function; increase blood circulation and oxygen supply; reduce the risk of metastasis (84, 113).
Resistance training (strength training, resistance exercise) Enhance metabolic function; delay cancer cachexia; inhibit tumor invasion (114).
HIIT Improve blood circulation and promote the remodeling of the TME (115).
Physical factor therapy Local hyperthermia Upregulate the expression of HSP70 on the surface of tumor cells to enhance the recognition efficiency of circulating tumor cells (116).
TENS Reduce pain-related stress responses; protect NK cell activity and reduce chronic inflammation activation (117).
Whole body vibration therapy Inhibit mechanical transfer and block the mechanical force-driven metastasis and dissemination (118).
Occupational therapy Daily activity training Reduce psychological burden; enhance functional activity ability; relieve pain and activity limitation caused by tumor metastasis (103).
Pain management Electrotherapy, cold and heat therapy Alleviate pain and stress responses, reduce the promoting effect of chronic pain on tumor metastasis; decrease the activation of pro-inflammatory pathways (119).
Traditional Chinese Medicine rehabilitation Acupuncture Regulate the HPA axis, reduce the secretion of stress hormones; inhibit pro-metastatic factors: control the secretion of inflammatory mediators, suppress pro-metastatic factors in the TME (107).
Chinese herbal medicines (such as Astragalus membranaceus and Ganoderma lucidum, etc.) Enhance immune function, improve the body’s immune surveillance ability, and reduce the risk of cancer cell spread (109).
Psychotherapy CBT, MBSR Relieve anxiety and depression; reduce HPA axis activation, decrease cortisol secretion, and inhibit chronic inflammation; suppress the deterioration of the TME: reduce the promotion of tumor cell migration and proliferation by negative emotions (111, 112).

4.2. Rehabilitation intervention strategies for various transfer locations

The metastasis of cancer is a critical phase in the advancement of the disease. Various cancer forms exhibit distinct proclivities for metastasis, targeting sites such as the bone, lung, liver, brain, lymph nodes, skin, and gastrointestinal system (120). For these metastatic sites, comprehensive rehabilitation therapies aim not only at functional recovery and pain management but also at preventing and mitigating tumor dissemination by modulating the TME and employing anti-inflammatory and immunological modulation mechanisms.

Rehabilitation options for bone metastases encompass physical therapy, pain management, functional training, and nutritional support (121). These treatments seek to fortify the musculature around the bones, strengthen the skeletal framework, and alleviate pain resulting from bone degradation (122, 123). Simultaneously, exercise and nutritional intervention can modulate the levels of inflammatory mediators like IL-6 and TNF-α, diminish the pro-inflammatory response within the bone microenvironment, and minimize the retention and invasion of tumor cells in bone tissue (124, 125). Moreover, suitable dietary assistance, including sufficient calcium and vitamin D, can facilitate the restoration of bone tissue by preserving bone density and improving immunological function, while mitigating the detrimental effects of tumor cells on the bone (126). Rehabilitation interventions for lung metastases concentrate on the modulation of respiratory function and the immune system. Respiratory training and aerobic exercise promote lung function and cardiovascular endurance, prevent lung infections, and augment the activity of T cells and NK cells, hence increasing immune surveillance in lung tissue and limiting cancer cell metastasis (127). Aerobic exercise enhances the body’s oxygen usage efficiency, ameliorates the hypoxic conditions in the lungs, and diminishes the proliferation rate of tumor cells in hypoxic environments (128). Additionally, chest physical therapy enhances respiratory muscle power, alleviates airway blockage, consequently augmenting lung airflow, diminishing local inflammation, and decreasing the likelihood of tumor cell dissemination via the vascular and lymphatic systems (129).

The rehabilitation options for liver metastases mostly emphasize immunological function and metabolic homeostasis (130). High-protein, low-fat dietary support aids in preserving the patient’s weight and nutritional status, bolsters the immunological response, particularly by augmenting the activity of anti-tumor immune cells (such as macrophages and T cells), and improves the capacity to eliminate tumor cells (131). Simultaneously, moderate physical training enhances hepatic blood circulation, fosters hepatocyte regeneration, modulates oxidative stress within the hepatic milieu, diminishes hepatocellular damage, and impedes tumor cell proliferation (132). Furthermore, consistent monitoring of liver function can effectively avert worsening and assist in optimizing the rehabilitation intervention strategy (133).

The rehabilitation strategy for brain metastases concentrates on restoring neurological function, enhancing cognitive ability, and managing pain and epilepsy (134). Physical therapy and occupational therapy facilitate the restoration of motor coordination, enhance cerebral blood flow, promote neural plasticity, and diminish the accumulation of inflammatory mediators such as IL-1β and TNF-α in the brain, thereby mitigating neurological damage resulting from tumor metastasis (135, 136). Cognitive training can assist patients in preserving or recovering brain function, enhancing cognitive abilities, and modulating the brain’s neural network to mitigate tumor-associated neurological impairments (137). Pain management and epilepsy prevention further mitigate pro-metastatic elements in the TME by diminishing neuroinflammation and excessive excitatory responses, while controlling neurotransmitter balance (138). Rehabilitation options for lymph node metastases encompass early detection and surveillance, complete therapy, and physical intervention (139). Advanced lymphatic drainage procedures actively facilitate the clearance of interstitial fluid and effectively mitigate lymphedema. Crucially, contemporary oncological consensus demonstrates that restoring lymphatic transport capacity does not exacerbate the risk of tumor cell dissemination. Instead, normalizing local lymphatic flow is postulated to alleviate interstitial fluid pressure-induced immunosuppression, thereby helping to restore immune surveillance within the regional lymph nodes and maintaining overall oncological safety (140). Moreover, suitable exercise interventions can stimulate immune cells inside the lymphatic system, augment the body’s immune surveillance, and inhibit the proliferation and dissemination of tumor cells (141). Targeted lymphatic rehabilitation therapies, such as manual lymphatic drainage and decongestive interventions, play a fundamental role in modulating local immune responses and resolving chronic tissue inflammation (142). By actively facilitating the clearance of interstitial fluid stasis, these therapies diminish the local accumulation of pro-inflammatory cytokines and alleviate mechanical stress within the tissue (143). Consequently, the restoration of physiological lymphatic function helps disrupt the chronic inflammatory pathways within the TME that would otherwise foster immune evasion and promote tumor dissemination, thereby reinforcing regional anti-tumor immune surveillance (144).

Rehabilitation for metastasis in the skin and gastrointestinal tract integrates local treatment, nutritional support, and physical training to modulate the immune response and inflammatory condition, thereby aiding in tumor growth control (145). Localized interventions, including dermatological care and physical modality therapy, can diminish local inflammatory responses and restore skin barrier integrity, therefore mitigating the danger of tumor dissemination in the dermis and gastrointestinal system (146, 147). Nutritional assistance facilitates nutrition absorption in the gastrointestinal tract and sustains digestive system function, hence improving the patient’s physical state and aiding in the equilibrium of the TME (148). Simultaneously, physical exercise improves the body’s antioxidant capacity, diminishes inflammatory responses, and strengthens the patient’s general immunity and cancer resistance (14).

Rehabilitation interventions for various metastatic cancer sites, utilizing interdisciplinary collaboration and tailored treatment programs, effectively modulate the TME, immunological function, and inflammatory response (149). They not only attain favorable outcomes in the restoration of physical functions but also proficiently impede the onset and advancement of tumor metastasis through multifaceted pathways, including immunological modulation, anti-inflammatory processes, and metabolic management. Through ongoing assessment of rehabilitation outcomes, alongside patient education and self-management, rehabilitation interventions can offer more tailored and holistic support for cancer patients, enhancing their long-term survival rates and quality of life while facilitating the overall recovery of their physical and mental well-being (Tables 3, 4).

Table 3.

Rehabilitation intervention strategies for various transfer location.

Metastatic site Intervention measures The main mechanism of action
Bone metastasis Physical therapy: functional training, strength training
Nutritional support
Stabilize bone structure and enhance muscle strength; reduce pro-inflammatory factors (IL-6, TNF-α) Maintain bone density (118, 121, 131).
Pulmonary metastasis Breathing exercises
Aerobic exercise
Improve lung function and enhance immune surveillance; relieve hypoxic conditions and inhibit tumor spread (51, 97, 103, 114).
Liver metastasis High-protein, low-fat diet
Low to moderate intensity exercise
Enhance immune function and improve the ability to resist tumor cells; regulate the liver microenvironment and reduce oxidative stress (130, 133).
Brain metastasis Physical therapy
Cognitive training
Pain management
Improve neural function and promote neural regeneration; reduce neural inflammation and regulate the balance of neurotransmitters (134, 135, 137).
Lymph node metastasis Lymphatic drainage
Moderate exercise
Promote lymphatic circulation; activate immune cells and reduce the risk of spread (139).
Skin metastasis Local care
Nutritional support
Repair the skin barrier and reduce local inflammation, enhance the body’s immune capacity (145, 148).
Gastrointestinal metastasis Nutritional support
Light physical training
Maintain digestive function and enhance physical fitness; reduce gastrointestinal inflammation and inhibit tumor spread (108, 130).

Table 4.

Comparative summary of clinical trials of rehabilitation interventions on cancer metastasis.

Intervention Cancer type Study design Outcome on metastasis Level of evidence
Aerobic exercise (moderate) Breast, Prostate, Colorectal RCT/Meta-analysis (150, 151) No significant reduction in metastasis incidence; improvement in immune markers and QoL Level 1 (high)
Resistance training Breast, Hematological RCT/Systematic Review (152) No direct effect on metastasis; improves muscle mass, physical function Level 1 (high)
HIIT Breast, Animal models Preclinical/Clinical Cohort (11) In animal models: reduced lung metastasis and enhanced CD8+ T cell activity; human evidence limited Level 2 (moderate)
Combined Aerobic + Resistance Mixed solid tumors RCT (153) Improved functional status; no significant effect on metastasis-free survival Level 1 (high)
Physical factor (Hyperthermia) Breast,GI (mostly preclinical) Preclinical/Clinical (154) Enhanced immune surveillance, reduced local recurrence, limited direct evidence on metastasis Level 2 (moderate)
TENS (pain management) Lung, Mixed Pilot Clinical/Animal (155) Improved NK cell function, reduced stress; insufficient direct evidence on metastasis Level 2 (moderate)
Mind-body (Yoga, Tai Chi, CBT) Breast, Colorectal, Lung RCT/Systematic Review (156) Reduced inflammation and stress hormones, no direct evidence for metastasis Level 1 (high)

RCT, Randomized Controlled Trial; QoL, Quality of Life; HIIT, High-Intensity Interval Training; GI, Gastrointestinal; TENS, Transcutaneous Electrical Nerve Stimulation; NK, Natural Killer; CBT, Cognitive Behavioral Therapy.

4.3. Cancer type and patient-specific considerations in rehabilitation interventions

Recent evidence underscores the importance of tailoring rehabilitation interventions according to cancer subtype, disease stage, and patient population. For hematological malignancies (such as leukemia, lymphoma, and myeloma), rehabilitation protocols emphasize infection prevention, fatigue management, and safe mobilization due to immunosuppression and cytopenias, as described in the ACSM (American College of Sports Medicine) and NCCN (National Comprehensive Cancer Network) guidelines (157, 158). In contrast, for solid tumors (e.g., breast, lung, colorectal), rehabilitation strategies are often disease- and stage-specific, focusing on surgical recovery, management of treatment-induced sequelae, and long-term functional maintenance (159). For instance, resistance and aerobic training are recommended for breast cancer survivors to address lymphedema and improve upper limb function, whereas for advanced lung cancer patients, pulmonary rehabilitation is prioritised (157).

Rehabilitation interventions should also be adapted to the phase of oncologic treatment: prehabilitation (prior to surgery/chemotherapy) aims to optimize baseline function and psychological resilience; during treatment, exercise is often reduced in intensity and carefully monitored to manage fatigue and immunosuppression; post-treatment, interventions focus on restoration of physical fitness, management of chronic sequelae, and prevention of recurrence. These phase-specific recommendations are supported by consensus statements from international bodies such as ACSM and ESMO (European Society for Medical Oncology) (159, 160).

Demographic and clinical characteristics, including age, sex, baseline fitness, and comorbidities, substantially influence rehabilitation planning (161). For older adults, exercise prescription must be individualized to accommodate frailty, fall risk, and polypharmacy (162). Pediatric and adolescent cancer survivors require age-appropriate, developmentally targeted programs (163, 164). Sex differences in rehabilitation outcomes (e.g., bone health, muscle mass retention) have also been reported, necessitating gender-sensitive approaches (165). Furthermore, patients with comorbidities such as cardiac or respiratory disease should undergo multidisciplinary assessment to ensure safety and efficacy (158).

Several clinical guidelines and position statements provide evidence-based recommendations for rehabilitation across cancer types and patient subgroups, including: (1) ACSM Guidelines for Exercise in Cancer Survivors (157); (2) NCCN Survivorship Guidelines (158); (3) ESMO Clinical Practice Guidelines (159).

4.4. Stakeholder-oriented practical implications and messaging

This review is intended to inform and empower a diverse range of stakeholders involved in the management and support of patients with cancer who are at risk of metastasis. For clinical professionals such as physicians, nurses, and palliative care teams, our findings underscore the importance of early and proactive integration of rehabilitation interventions within oncology care pathways to improve patient outcomes and quality of life. Rehabilitation and palliative care specialists can utilize the synthesized evidence to develop individualized, stage-appropriate rehabilitation protocols. In addition, dietitians and allied health professionals are encouraged to collaborate in multidisciplinary teams to address the physical, nutritional, and psychosocial factors pivotal to metastasis prevention. Researchers in areas including personalized rehabilitation, oncology, exercise science, and integrative medicine will find this review highlights key research gaps and provides direction for future investigations. Most importantly, for patients and their families, our review emphasizes the significance of evidence-based rehabilitation strategies, encourages open communication with healthcare providers, and urges caution against adopting non-validated interventions that may be encountered on social media or other non-scientific sources. By specifically tailoring our key messages, we aim to facilitate the translation of current evidence into clinical decision-making, collaborative multidisciplinary care, research innovation, and patient empowerment.

5. Potential rehabilitation intervention strategies from an interdisciplinary approach

5.1. Integration of physical therapy and occupational therapy

The amalgamation of physical therapy and occupational therapy in contemporary rehabilitation medicine exemplifies a robust interdisciplinary synergy. Multi-dimensional intervention measures can substantially improve patients’ functional recovery and quality of life (166). Physical therapists and occupational therapists collaborate to create tailored rehabilitation regimens that address patients’ individual requirements, ultimately enhancing rehabilitation outcomes on both physiological and psychological dimensions (167, 168). The primary objective of physical therapy is to rehabilitate patients’ physical functions via structured movement and strength training (169). Detailed functional examinations identify functional impairments, emphasizing muscle strength, flexibility, balance, postural control, and cardiopulmonary endurance. To attain the objective of rehabilitating and augmenting patients’ motor functions, individualized exercise regimens are formulated, generally encompassing aerobic exercise, resistance training, balance training, and stretching (152). Physical therapy can effectively mitigate functional deficits resulting from surgery, trauma, or chronic diseases using various methods (170). Occupational therapy emphasizes patients’ autonomy and adaptation in daily activities, seeking to assist individuals in restoring their functions and achieving independent living (168). Occupational therapists formulate individualized occupational training plans by conducting comprehensive evaluations of everyday activities, encompassing fundamental self-care tasks (such as dressing, hygiene, and nutrition) as well as intricate job, familial, and social engagements (166). In this process, occupational therapists implement specialized assistive devices (such as adaptive utensils and long-handled tools) and modify the environment’s layout to enhance patients’ self-care capabilities and efficiency in daily tasks, even when their physical functions remain impaired (171). This alleviates the caregiving burden on patients and their families while simultaneously bolstering patients’ self-esteem and autonomy, therefore enhancing their mental well-being (168).

The comprehensive combination of physical therapy and occupational therapy encompasses the restoration of bodily functions, the increase of daily activity capabilities, and the improvement of patients’ mental health and social adaptability. By collaborating closely with physical therapists, occupational therapists can more effectively integrate the motor skills acquired in physical therapy into particular daily living tasks. For instance, improvements in lower limb strength and balance achieved through physical therapy can be directly applied to daily activities such as transferring from bed to chair, walking on uneven surfaces, or climbing stairs. Occupational therapists then incorporate these skills into individualized training for tasks like safely navigating the bathroom, preparing meals in the kitchen, or using public transportation, thereby enabling patients to perform essential self-care and community activities more independently and confidently. Occupational therapists modify the home and work surroundings of patients who have been bedridden or have restricted mobility for an extended period, optimizing the outcomes of physical therapy to improve self-care capabilities and social engagement (172). By assessing and modifying patients’ work settings, occupational therapists can significantly diminish the effects of functional impairments on employment, thus enhancing job efficiency and occupational engagement. This facilitates patients’ social reintegration and offers essential assistance for their employment resumption and restoration of social functions (173).

The amalgamation of physical therapy and occupational therapy in cancer rehabilitation must be predicated on a thorough evaluation within the context of the International Classification of Functioning, Disability and Health (ICF) (Figure 5). This framework offers a standardized instrument for assessing functional deficits in cancer patients across four dimensions: bodily functions and structures, activities and involvement, environmental factors, and personal aspects (174). Using postoperative upper limb lymphedema following breast cancer surgery as a case study, physical therapists employ the ICF framework to assess the extent of diminished shoulder joint range of motion and muscle strength deficits, subsequently formulating a graded compression treatment plan integrated with neuromuscular electrical stimulation based on environmental factors (175, 176). Concurrently, occupational therapy concentrates on evaluating activity limitations, such as fine motor tasks and tool utilization, utilizing a 3D motion capture system to detect compensatory postures, such as a cervical forward inclination angle exceeding 15°, during activities of daily living (ADL) like eating, grooming, and mobile phone usage, and then devises task-oriented training, such as adaptive utensil training, to mitigate the risk of joint strain (177). The ICF framework is pivotal for interdisciplinary collaboration: physical therapy addresses body function levels (e.g., enhancing postural transfer ability via whole-body vibration therapy) (178), whereas occupational therapy emphasizes the participation dimension (e.g., employing virtual reality to replicate a supermarket shopping environment to improve community activity participation) (179). Both disciplines align their intervention objectives by utilizing the ICF core data set. This indicates that using the bio-psycho-social model of the ICF into cancer rehabilitation can transcend the constraints of conventional medical metrics and effectively realize “function-oriented” precise intervention.

Figure 5.

Diagram illustrating the International Classification of Functioning, Disability, and Health (ICF) framework with interconnected boxes labeled health condition, body functions and structure, activity, participation, environmental factors, and personal factors, each represented by corresponding icons.

Conceptual framework of the biopsychosocial approach in cancer rehabilitation based on the WHO ICF model. This diagram depicts the dynamic and bidirectional interrelationships between a patient’s health condition and their overall functioning. The core domains of functioning include body functions and structure, activity, and participation. Crucially, these clinical and functional outcomes are continuously modulated by contextual elements, encompassing environmental factors and personal factors. In the context of cancer metastasis, this holistic framework guides multidisciplinary rehabilitation teams to design comprehensive, patient-centered interventions that not only mitigate biological impairments but also optimize functional independence and societal participation. Created by the authors using EdrawMax.

Physical therapy and occupational therapy are intricately interconnected and mutually reinforcing during all phases of the patient’s rehabilitation (166). In the acute rehabilitation phase, physical therapy aims to restore fundamental capabilities (178), whereas occupational therapy assists patients in preserving essential living skills through the utilization of assistive equipment (103). Upon entering the recovery phase, physical treatment augments the patient’s motor skills, while occupational therapy facilitates the gradual restoration of complex functions, including job and leisure activities, so facilitating societal reintegration (180). As rehabilitation advances, the interdisciplinary team consistently evaluates the patient’s functional development and adaptively modifies the rehabilitation plan according to their individual recovery status to optimize the attainment of rehabilitation objectives (181). This collaborative method enhances the patient’s comprehensive recovery while optimizing the efficiency of medical resource consumption through interdisciplinary teamwork (180).

5.2. The combination of nutrition and physical therapy

The integration of nutrition and physical therapy may play a significant role in accelerating the recovery process of patients, enhancing their overall health and quality of life (182). During the rehabilitation period, the body requires more energy and nutrients to support muscle repair, wound healing, and the restoration of the immune system (Table 5). Dietitians conduct detailed nutritional assessments to ensure that patients consume adequate and balanced nutrition to meet the physiological demands of recovery (183). Protein is a key element for muscle repair and growth, especially during physical therapy when muscles are stimulated by exercise and training, resulting in minor damage. Appropriate protein intake helps in the reconstruction and growth of muscle fibers, reduces muscle atrophy, and enhances muscle strength and endurance. Studies have shown that a diet rich in high-quality protein, such as lean meat, fish, beans, and dairy products, can significantly accelerate muscle repair and improve rehabilitation outcomes (184). Energy intake is also crucial during the rehabilitation process. Physical therapy often involves high-intensity exercise and training, which requires a large amount of energy support. Dietitians design high-energy diet plans based on the energy needs of patients to ensure they maintain sufficient energy reserves during rehabilitation, thereby reducing fatigue, enhancing endurance and physical strength, and enabling them to better participate in physical therapy (185).

Table 5.

Essential components of nutritional intervention in the rehabilitation process.

Nutrition category Main source Core function
High-quality protein Lean meat, fish, beans and dairy products Promote muscle repair and enhance immune function (55, 184).
Carbohydrates Whole grains, fruits Provide energy and relieve fatigue (190).
Fat Nuts, olive oil, deep-sea fish Stable energy source, supporting cell functions (186).
Vitamin C and E Citrus fruits and green leafy vegetables Antioxidant, promoting tissue repair (196).
Vitamin D and calcium Dairy products, fish, egg yolks Maintain bone health and prevent bone loss (188, 196).
Zinc and magnesium Seafood, nuts, and beans Regulate muscle and nerve functions and enhance immunity (189).

Additionally, a reasonable intake of carbohydrates provides a sustainable energy source for patients, while fats serve as a secondary energy source, providing stable support for the long-term rehabilitation process (186). The supplementation of micronutrients (such as vitamins and minerals) also plays a vital role in the rehabilitation process. Vitamins C and E have antioxidant properties, which can reduce oxidative stress caused by intense exercise or disease, thereby promoting tissue repair (187). Vitamin D and calcium are crucial for bone health, especially for patients who have been bedridden for a long time or have limited movement, as they help maintain bone density and prevent bone loss (188). Minerals such as zinc and magnesium are involved in muscle contraction, nerve conduction, and immune function regulation (189). Therefore, during the rehabilitation process, dietitians ensure that the intake of these micronutrients is in the best balance based on the specific needs of patients (190). Physical therapy intervention, through systematic exercise and strength training, gradually restores the patient’s motor function and physical capacity. Physical therapists adjust the intensity and content of training based on the patient’s nutritional status to ensure the safety and effectiveness of the rehabilitation process. For example, for patients with poor nutritional status, physical therapists may design more moderate training programs to prevent excessive fatigue or secondary injuries caused by training. As the patient’s physical fitness improves and nutritional status enhances, physical therapists gradually increase the intensity of training to promote further recovery of muscle strength, cardiopulmonary function, and overall endurance (191). Common rehabilitation training programs include aerobic exercise, resistance training, balance training, and flexibility training, which not only help in the recovery of muscle strength but also improve cardiopulmonary endurance and overall motor ability (192, 193).

Proper nutritional support supplies essential energy and substrates for physical training, facilitating the repair and enhancement of muscles, bones, and the nervous system (194). Structured exercise regimens stimulate muscle hypertrophy, improve cardiovascular function, and augment metabolic capacity, thereby optimizing nutrient absorption and utilization (195). This reciprocal enhancement not only aids in the restoration of physiological functions in patients but also bolsters their psychological resilience and rehabilitation confidence through improved physical fitness and self-care capabilities (196). The integration of nutrition and physical therapy further elevates patients’ psychological well-being and overall quality of life. Optimal nutritional status and suitable exercise can alleviate anxiety and depression while fostering self-esteem and self-efficacy (197).

5.3. Integration of psychological support and clinical intervention

The profound integration of psychological support and therapeutic treatment also uncovers possible interdisciplinary synergies. This interdisciplinary therapeutic strategy efficiently facilitates patients’ physiological recovery while considerably improving their psychological adaptability and general quality of life. The diagnosis of cancer frequently induces significant psychological distress, with patients commonly encountering adverse emotions including anxiety, depression, dread, and despair (198). These emotions adversely impact patients’ quality of life and hinder their adherence to treatment and treatment outcomes. Rehabilitation psychological intervention, by thoroughly comprehending patients’ psychological states, devises individualized psychological intervention strategies, encompassing psychological counseling, emotional management skills training, relaxation techniques, and supportive group activities (199). Research indicates that these psychological interventions can markedly diminish patients’ anxiety and despair, enhance psychological resilience, and assist them in managing emotional changes and physiological problems throughout therapy (200).

In individualized psychological counseling, psychotherapists employ effective treatment modalities, such as cognitive behavioral therapy, to assist patients in reevaluating and modifying their perceptions of illness, thereby diminishing negative beliefs regarding both the disease and its treatment (111, 169). By assisting patients in identifying irrational negative thought patterns, psychotherapists can facilitate the development of more constructive coping techniques, so enabling them to sustain a more stable emotional state amongst the uncertainty of treatment plans. For example, common irrational negative thought patterns in cancer patients include catastrophizing (e.g., “I will never recover from this illness”), overgeneralization (e.g., “Since my treatment has side effects, nothing will go well for me”), and hopelessness (e.g., “There is nothing I can do to help myself”) (201). CBT helps patients recognize and challenge the validity of these distorted thoughts. Coping techniques taught in CBT include cognitive restructuring, where patients learn to replace negative thoughts with more balanced and realistic perspectives (such as, “Although treatment is challenging, there are steps I can take to improve my quality of life”), as well as behavioral activation, problem-solving skills, and relaxation techniques. By applying these strategies, CBT enables patients to reduce negative perceptions and beliefs related to their illness and treatment, thus improving psychological resilience and fostering more adaptive emotional and behavioral responses (202). The cultivation of emotional regulation abilities is a crucial element of psychological intervention. Through the instruction of relaxation techniques, deep breathing exercises, and mindfulness meditation, psychotherapists can assist patients in enhancing their self-regulation during emotional swings and preventing emotional decline (203). For example, relaxation training can diminish patients’ anxiety levels (204), but mindfulness meditation can improve their psychological focus (205), so augmenting their sense of involvement and control in therapy. These skills not only assist patients in preserving emotional stability during therapy but also markedly enhance their overall mental health, establishing a more robust psychological support base for treatment (206, 207).

Collaborative group activities can significantly contribute. In groups, patients can express their emotions and experiences, acquire understanding and support from peers, and this communal resilience can significantly mitigate individual feelings of isolation and powerlessness (208). Group activities create a secure setting for emotional expression, enabling patients to alleviate stress, cultivate strong social relationships, and enhance their confidence in the rehabilitation process (209). Research indicates that patients engaged in supportive group activities typically exhibit improved emotional regulation and life adaption, hence bolstering their psychological resilience (203). From a therapeutic treatment standpoint, the incorporation of psychological support enhances patients’ emotional well-being and augments the overall efficacy of medical interventions (210). Following psychological support, patients can more effectively comprehend each phase of the treatment plan and engage in the treatment with a more constructive disposition (211, 212). Psychotherapists can effectively collaborate with the medical team to align patients’ psychological and physiological needs within the treatment plan, so assuring holistic care for both body and mind during the treatment process (213). This integrated treatment paradigm enhances patients’ quality of life and diminishes physiological consequences resulting from psychological stress. This interdisciplinary cooperation model provides patients with rehabilitation support at the physiological level, as well as complete care at the psychological and social levels, exemplifying the fundamental principle of “holistic treatment” in contemporary rehabilitation medicine.

5.4. Integration of physical activity into multidisciplinary cancer care

The effective implementation of physical activity interventions for cancer patients necessitates seamless integration into a broader multidisciplinary care plan. This approach involves close collaboration among physicians (who assess medical stability and contraindications), rehabilitation experts (physical and occupational therapists who design and tailor activity plans), dietitians (who optimize nutritional support for safe exercise), pharmacists (who review medication interactions and side effects), social workers (who address psychosocial barriers), and, crucially, patients and their families (who provide feedback and support adherence) (13). Multidisciplinary team meetings can facilitate real-time adjustments to rehabilitation protocols, ensuring that physical activity is personalized and safely aligned with the patient’s evolving clinical status.

The question of whether physical activity interventions should be supervised remains a subject of ongoing debate. Current evidence suggests that supervised exercise programs, especially in the early phases of rehabilitation or for high-risk patients, are associated with improved adherence, safety, and outcomes (161). Practical models include in-clinic supervision, structured group sessions, and remote monitoring using wearable devices and telehealth platforms. For lower-risk patients or those transitioning to survivorship, hybrid or home-based programs with periodic professional oversight may be appropriate (214).

However, there remains a gap in the literature regarding standardized guidelines on supervision intensity, duration, and modality across different cancer populations and treatment stages. To address this, we propose (1) individualized risk stratification to guide the level of supervision, (2) integration of digital health monitoring tools for real-time feedback, and (3) ongoing interdisciplinary communication to promptly identify and address emerging safety concerns. Further research is warranted to establish evidence-based standards for the supervision and monitoring of physical activity in oncology rehabilitation.

6. Novel approaches and advanced technologies

6.1. Digital health and remote monitoring for cancer rehabilitation

In the realm of rehabilitation medicine, novel methodologies and advanced technology from an interdisciplinary viewpoint are continually emerging, showcasing significant potential in the prevention and rehabilitation of cancer metastasis. These technologies substantially improve the scientific rigor and customization of the intervention while also effecting transformative changes in the rehabilitation experience and quality of life for cancer patients.

In the domain of digital health and remote monitoring technologies, smart devices like smartwatches and health trackers have significantly contributed to the rehabilitation treatment of cancer patients (215). These gadgets can monitor patients’ physiological data in real time, including heart rate, activity levels, and sleep quality, while also documenting the execution of rehabilitation exercises. For individuals at elevated risk of cancer metastasis, this data can assist medical teams in recognizing physiological variations and potential health hazards (216, 217). By monitoring patients’ activity levels and weariness, the treatment team can swiftly modify the rehabilitation plan, enhance the patient’s immune function, and avert the exacerbation of inflammatory conditions, thereby diminishing the chance of metastasis (218). The utilization of remote rehabilitation platforms has transcended geographical limitations, allowing patients to perform guided rehabilitation activities at home, particularly beneficial for postoperative or physically compromised cancer patients (219). These systems, via specifically built mobile applications, offer tailored rehabilitation assistance and incorporate video call functions, enabling real-time interaction between patients and therapists (220). This ongoing and effective rehabilitation support aids cancer patients in sustaining the efficacy of systemic treatment, improving treatment adherence, and thereby diminishing the likelihood of cancer cell dissemination (221). However, limitations include variable data accuracy, technology literacy requirements for patients, and concerns regarding data privacy and security (222).

6.2. Virtual and augmented reality in functional and pain management

Virtual reality (VR) and augmented reality (AR) technologies have exhibited distinct advantages in the rehabilitative training of cancer patients. VR is defined as an immersive technology that completely replaces the user’s physical environment with a computer-generated, interactive digital simulation. In contrast, AR overlays digital information—such as visual graphics, spatial guidance, or auditory cues—onto the real-world environment in real-time. The fundamental difference lies in the level of environmental immersion: VR completely isolates the user from the physical world to create a newly simulated experience, whereas AR supplements the actual physical surroundings, allowing patients to remain aware of and interact with their real-world environment alongside virtual enhancements (223). By utilizing these immersive and augmented situations, patients can engage in physical therapy and exercise training within highly simulated and controlled environments (224). For cancer patients, particularly those susceptible to bone metastases or with restricted mobility post-surgery, VR technology facilitates safe and regulated movement training, significantly diminishing the likelihood of falls or injuries (225). Moreover, virtual reality technology may replicate everyday movements, such as grasping things, ambulating, or ascending and descending stairs, assisting patients in regaining fundamental functions and developing muscle memory, therefore improving their functional capabilities in real life (226, 227). In the realm of pain management, virtual reality technology diverts patients’ focus from pain via immersive activities (228). This non-pharmacological intervention is especially advantageous for the chronic pain frequently encountered by cancer patients, since it diminishes dependence on analgesics and mitigates the adverse effects of medications on the immune system, therefore reducing the chance of metastasis (229).

6.3. Artificial intelligence and big data for precision rehabilitation

Artificial intelligence (AI) and big data analytics significantly contribute to the management of cancer metastatic rehabilitation. Through the analysis of extensive rehabilitation data, AI technology may develop sophisticated predictive models to anticipate patient rehabilitation progress and potential metastatic concerns (230). For example, utilizing patients’ medical histories, real-time monitoring data, and genetic traits, AI models may precisely determine which patients exhibit a greater propensity for metastasis and offer tailored intervention recommendations (231). Regarding the prevention of cancer metastasis, AI can assist the treatment team in optimizing rehabilitation plans by assessing patients’ immune system status, inflammatory markers, and physical activity data, thereby rendering rehabilitation therapies more precise (230). Simultaneously, AI may adapt the intensity, frequency, and type of exercise according to patients’ rehabilitation progress, guaranteeing that their functional recovery remains within a safe range (232). Moreover, AI-driven big data analysis can amalgamate multi-dimensional patient information (including psychological state, nutritional status, and treatment adherence) to formulate more comprehensive rehabilitation strategies, thereby improving patients’ overall health and immune function while diminishing the likelihood of cancer metastasis and recurrence (233235).

Through the integration of the aforementioned novel methodologies and advanced technologies, rehabilitation medicine has transitioned from a “experience-driven” approach to a “data-driven” paradigm in the intervention of cancer metastasis. These technologies augment the scientific rigor, accuracy, and efficacy of rehabilitation treatment, while also bolstering patients’ sense of involvement and confidence in the therapeutic process (236238). In the future, enhanced interdisciplinary collaboration and technological integration will facilitate the advancement of personalized rehabilitation plans, offering more comprehensive metastasis prevention and functional recovery support for cancer patients, thereby improving their quality of life and long-term prognosis.

AI-guided exercise plans represent a novel paradigm in personalized cancer rehabilitation. AI algorithms can process large volumes of physiological, behavioral, and historical health data to generate real-time, individualized exercise recommendations, with consideration of patient comorbidities, treatment cycle, and symptom fluctuations. Nonetheless, translation into clinical practice is challenged by the need for validation, clinician oversight, and ethical considerations related to algorithmic transparency. Despite these promising developments, there remain significant challenges. Patient access to advanced technologies may be limited by cost or digital divides, and there is a need for rigorous clinical validation of these tools in diverse cancer populations. Additionally, integration into existing care pathways requires multidisciplinary collaboration and ongoing user education. Future research should further follow the Transparency In The reporting of Artificial INtelligence (TITAN) guidelines. These guidelines provide a standardized and comprehensive framework designed to rigorously evaluate and report the methodological design and clinical validation of AI models, thereby enhancing the transparency, reproducibility, and clinical translation of AI research reports (239).

To synthesize these advancements, Table 6 provides a comprehensive overview of novel approaches and advanced technologies in cancer rehabilitation, highlighting specific applications and their associated clinical improvements.

Table 6.

Summary of novel approaches and advanced technologies in cancer rehabilitation.

Advanced technology Rehabilitation activities Clinical statistics
AI & Big Data Explainable AI (e.g., XGBoost combined with SHAP) for predicting mortality and recurrence risk based on multi-omics and clinical data (240). Outperformed traditional models in predicting metastatic cancer survivability (C-index=0.70 vs. 0.66); increased precision in personalized oncology workflows (241).
Telehealth & Remote Monitoring Platforms Supervised, personalized exercise programs delivered via telehealth (aerobic and resistance training); remote monitoring of functional tests (e.g., 30-second chair stand) (242). Equivalent efficacy to in-person programs; significant improvements in physical function and muscular endurance; reduced perceived cognitive difficulty (243).
Nanotechnology & Wearable Sensors Continuous, non-invasive monitoring of sweat biomarkers (e.g., cortisol, lactate) using molecularly imprinted polymer electrochemical patches (244, 245). Enabled dynamic, real-time assessment of physiological stress and exercise intensity; high selectivity with less than 3.76% signal attenuation over long-term use (244).
VR/AR Immersive VR distraction therapy during cancer treatments; AR-assisted spatial guidance for physical rehabilitation (246). Reduced chronic pain intensity and procedure-related anxiety; enhanced functional mobility and patient engagement in rehabilitation protocols (247).

6.4. Safety considerations and risk management in exercise oncology

The implementation of exercise interventions in cancer rehabilitation must be carefully balanced with safety considerations, given the unique risks associated with oncologic populations (248). Exercise is generally recognized as safe and beneficial for most cancer patients; however, several contraindications and risk factors should be considered (249). Absolute contraindications to exercise include severe anemia, acute infections, uncontrolled pain, significant cardiopulmonary compromise, and the presence of unstable bone lesions that may predispose patients to pathological fractures, particularly in those with bone metastases. Relative contraindications, such as thrombocytopenia or moderate anemia, require individualized assessment and modified exercise intensity (250).

Risk management strategies involve pre-exercise screening by a multidisciplinary team, ongoing symptom monitoring, and immediate cessation of exercise in the presence of warning signs such as chest pain, sudden dyspnea, dizziness, or new bone pain (251). Exercise prescriptions should be tailored according to each patient’s clinical status, treatment phase, and functional capacity, with close supervision for high-risk individuals (252). The integration of digital health monitoring and remote supervision can further enhance safety by enabling real-time assessment and rapid response to emergent issues (253). Continuous staff education and patient counseling are critical to ensure both safety and adherence throughout the rehabilitation process (254).

7. Challenges and future prospects of rehabilitation interventions

7.1. Challenges of individual variability and psychological factors

Individual differences present considerable problems in the prevention and recovery of cancer metastases. Each cancer patient possesses distinct physiological traits, genetic profiles, and immunological responses, resulting in the same therapy and rehabilitation strategies yielding significantly varied outcomes among patients (255). For example, during chemotherapy, radiation, or targeted therapy, several patients may demonstrate entirely distinct side effects or therapeutic results. This not only impedes the seamless advancement of treatment but may also modify the dynamics of metastatic risk (256). Consequently, developing individualized rehabilitation strategies for cancer metastasis necessitates a thorough evaluation of each patient’s distinct physiological characteristics, pathological mechanisms, and therapy responses (257, 258). To realize this comprehensive evaluation, a variety of assessment tools and procedures are utilized. These include gene mapping or genetic profiling to identify mutations or genetic variants that may impact disease progression and treatment response. Biomarkers such as circulating tumor cells, circulating free DNA, and protein markers are regularly monitored to assess disease status and therapeutic efficacy (259, 260). In addition, patients undergo regular clinical follow-up visits and imaging studies, allowing for dynamic monitoring of the treatment course. Continuous assessment through laboratory tests, symptom evaluation, and functional status measurements ensures timely adjustment of rehabilitation strategies and lends authenticity and reliability to the evaluation process (261, 262). The psychological state, emotional variations, and attitudes towards the disease and treatment acceptance of patients considerably affect the efficacy of rehabilitation programs (263, 264). Emotional anxiety, despair, and treatment resistance can impair immunological function, which is a significant factor in the proliferation and spreading of cancer cells (265, 266). Consequently, rehabilitation strategies for cancer metastasis must encompass not only physiological treatment but also extensive psychological support and emotional management to attain multifaceted intervention objectives (267).

7.2. Continuity in rehabilitation and the role of emerging technologies

The continuity and consistency throughout the rehabilitation process present a considerable difficulty in preventing cancer spread. Cancer patients may disrupt their rehabilitation programs due to medication side effects, physical weariness, or diminished motivation, therefore heightening the risk of cancer spreading during periods of instability or interruption in the rehabilitation process (268). Consequently, the rehabilitation team must exhibit significant flexibility and reactivity, enabling prompt adjustments to the rehabilitation plan based on the patient’s treatment progress and specific circumstances (269). For patients undergoing chemotherapy, the rehabilitation plan may necessitate a reduction in exercise intensity to mitigate physical strain, while addressing immune function decline through nutritional support and psychological intervention, thereby diminishing the likelihood of cancer cell dissemination (270).

Technological progress has introduced novel methods for the prevention and rehabilitation of cancer metastasis, although it also presents significant obstacles (271). Advanced technologies, including artificial intelligence, big data analytics, and nanotechnology, provide a scientific foundation for individualized rehabilitation (272, 273). Specifically, nanotechnology assists in individualized rehabilitation through the deployment of advanced wearable and implantable nanosensors (274). These nanoscale diagnostic tools enable the continuous, non-invasive monitoring of critical physiological biomarkers, such as metabolic fluctuations, inflammatory cytokines, and oxidative stress levels directly from sweat or interstitial fluid during exercise (275). By capturing these real-time molecular insights, rehabilitation teams can precisely tailor the intensity and duration of physical therapies to a patient’s immediate physiological tolerance, thereby optimizing recovery while minimizing the risk of exercise-induced systemic stress (276). Through the real-time analysis of patients’ physiological data and illness progression, AI technology can assist the treatment team in predicting the likelihood of cancer spreading and devising extremely precise intervention strategies (277). For example, several studies have reported that the implementation of AI–assisted clinical decision support systems can improve the accuracy of cancer-related risk predictions by 15–20% compared to conventional methods (278, 279). Moreover, data-driven and AI-supported rehabilitation management has been shown to enhance patient adherence and the overall effectiveness of individualized rehabilitation interventions (280). These findings underscore the tangible impact of advanced technologies on both the assessment and management of patients with metastatic cancer. Utilizing these forecasts, the rehabilitation team can formulate preemptive anti-inflammatory and immune-boosting therapies. Nonetheless, the implementation of these novel technologies requires validation through rigorous scientific research to ascertain their efficacy, safety, and broad applicability. The expenses and intricacies associated with emerging technologies may impose greater demands on patients, medical institutions, and rehabilitation teams (281). Achieving technological accessibility and universality with constrained resources is a pressing issue that requires resolution (282).

7.3. The importance of patient education and social support systems

Patient education and social support are essential components in the recovery phase of cancer metastasis (283, 284). Patients and their families may possess insufficient understanding of tumor metastatic mechanisms and rehabilitation treatments, resulting in a failure to comprehend the necessity of rehabilitation interventions and the significance of sustained commitment (285). Consequently, rigorous patient education is essential, particularly in disseminating knowledge about the risk factors associated with cancer metastasis (including chronic inflammation and lifestyle) and rehabilitation techniques, to enable patients to engage actively in their rehabilitation process (286, 287). Cancer patients may encounter adverse feelings, including loneliness, anxiety, and sadness throughout rehabilitation, which may further compromise immune function and elevate the chance of metastasis (288, 289). Consequently, establishing a robust social support network and psychological intervention system for patients might augment their rehabilitation motivation, bolster their confidence in life, and thereby indirectly diminish the likelihood of cancer spreading (290, 291).

Individual characteristics, psychological variables, and the interplay between technology and social support are essential components that must be considered in the rehabilitation intervention for cancer metastases (292). Enhancing interdisciplinary collaboration, refining personalized rehabilitation approaches, and advancing technological innovations can effectively tackle various challenges in cancer metastasis prevention, offering comprehensive support for patients and ultimately enhancing their long-term prognosis and quality of life (293).

To further strengthen the interdisciplinary framework of metastasis rehabilitation, integrated treatment models involving multidisciplinary teams (MDTs) have become standard practice in many comprehensive cancer centers (294). Typical MDTs comprise oncologists, rehabilitation physicians, physiotherapists, occupational therapists, psychologists, nutritionists, and social workers. These teams work collaboratively to design and implement individualized rehabilitation plans tailored to the complex needs of patients at risk for or experiencing metastasis (295).

One commonly employed integrated model is the MDT case conference approach, in which regular meetings are held to discuss each patient’s oncologic status, functional assessment, psychosocial needs, and progress in rehabilitation (296). For example, a patient with lung cancer and bone metastases may be presented at a weekly MDT meeting: the oncologist discusses current tumor management, the rehabilitation specialist evaluates physical limitations and risk of complications, while the physiotherapist and occupational therapist develop a tailored exercise and adaptation plan. The psychologist addresses emotional needs, and the nutritionist adjusts dietary recommendations to support systemic treatment and rehabilitation. This collaborative and dynamic approach allows the team to promptly modify interventions according to changes in the patient’s condition, treatment side effects, and personal goals (297).

Case studies have illustrated the effectiveness of these models. For instance, a published case from a tertiary cancer center detailed how an MDT developed a comprehensive rehabilitation protocol for a breast cancer patient with spinal metastasis. Through coordinated interventions, including pain management, mobility training, adaptive equipment provision, and ongoing psychosocial support, the patient achieved improved functional independence and quality of life, with better adherence to both oncologic and rehabilitation treatments (298, 299).

Moreover, the integration of digital health platforms into MDT workflows enables remote monitoring and real-time communication among team members and with patients, further enhancing continuity of care. These team-based, patient-centered approaches have been shown to improve functional outcomes, reduce complications, and increase patient satisfaction in cancer metastasis rehabilitation (300, 301).

7.4. Balanced view and current evidence limitations

While numerous studies have highlighted the potential benefits of rehabilitation interventions in improving quality of life and functional status in cancer patients, the evidence on their direct effect in preventing or reducing cancer metastasis remains inconclusive. Several systematic reviews and clinical studies report that, although exercise and other rehabilitation approaches can enhance physical function and psychological well-being, their direct impact on metastasis-free survival or delayed metastatic progression is less clear (150, 302). For example, some randomized controlled trials have not demonstrated a statistically significant difference in metastatic outcomes between patients receiving rehabilitation interventions and those receiving standard care. These neutral or inconclusive findings may be attributed to methodological shortcomings, primarily small sample sizes and the profound heterogeneity of exercise protocols. Variations in exercise modality, intensity, frequency, and duration across different studies make cross-study comparisons and the establishment of standardized clinical guidelines difficult (303).

Furthermore, a significant gap exists between preclinical successes and clinical realities. While animal models have provided robust mechanistic insights into how exercise or rehabilitation modifies the TME and immune responses, translating these in vivo findings into human clinical practice remains highly challenging. Animal models often fail to replicate the complex genomic heterogeneity of human tumors, the compounding effects of concurrent systemic therapies, and the prolonged, multifactorial clinical course experienced by cancer patients.

Moreover, certain high-risk patient groups—such as those with advanced disease, bone metastases, or severe comorbidities—may not experience the same benefits from rehabilitation interventions, and in some cases, could be at risk of adverse events if interventions are not properly individualized and closely monitored (304). This underscores the necessity for robust pre-intervention risk assessments and personalized rehabilitation plans that take into account the patient’s unique clinical status, cancer stage, and treatment goals.

It is also important to note that most current studies primarily focus on surrogate or secondary endpoints (such as physical function, fatigue, or quality of life) rather than metastasis or overall survival as primary outcomes. Crucially, there is a distinct lack of long-term metastatic outcome data. Most clinical trials feature relatively short follow-up periods, which are insufficient to capture latent metastatic events. The lack of high-quality, long-term trials specifically addressing metastatic progression limits our ability to draw definitive conclusions about the anti-metastatic effect of rehabilitation (243). Therefore, rehabilitation interventions should not be viewed as universally suitable or beneficial for all cancer patients across all disease stages. The design and implementation of rehabilitation strategies must be carefully tailored and supported by multidisciplinary teams, with continuous re-evaluation and monitoring to ensure both safety and efficacy.

Further high-quality, large-scale, and long-term studies are required to clarify the precise role of rehabilitation in metastasis prevention and management, and to identify which patient subgroups are most likely to benefit (305). Until then, a cautious and individualized approach is warranted, balancing the potential benefits of rehabilitation against the possible risks in vulnerable populations.

Despite these limitations, the synthesis of current evidence carries profound overall clinical implications, advocating for a paradigm shift from traditional, reactive rehabilitation to proactive, precision-based oncology rehabilitation. Integrating tailored exercise, physical modalities, and psychosocial support into the standard continuum of multidisciplinary cancer care can optimize the systemic neuroendocrine-immune network and remodel the local TME, creating a less permissive state for metastatic colonization. To bridge the existing translational gap between preclinical success and clinical reality, future research must prioritize several strategic directions. First, future RCTs must pivot from relying solely on secondary quality-of-life metrics to prioritizing metastasis-free survival and overall survival as primary endpoints. Second, research should integrate liquid biopsies and multi-omics profiling to continuously monitor metastatic risk, enabling the formulation of precise “exercise dosing” tailored to a patient’s real-time immune and inflammatory biomarker fluctuations. Third, deeper investigations are required to map the exact molecular docking mechanisms and intracellular signaling cascades triggered by specific physical modalities. Furthermore, clinical trials must be designed with extended follow-up periods exceeding one year to accurately capture latent metastatic events and evaluate the sustained efficacy of long-term rehabilitation adherence. Finally, future studies should utilize digital health platforms, wearable nanosensors, and AI-driven analytics to harmonize intervention protocols, thereby ensuring reproducibility across diverse global cohorts.

8. Conclusion

This review examines the multifaceted function of rehabilitation interventions in avoiding cancer metastasis, emphasizing the need of interdisciplinary collaboration in this domain. By synthesizing expertise from several fields including clinical medicine, exercise therapy, physical modality therapy, occupational therapy, and psychotherapy, tailored and holistic treatment strategies can be devised for patients, significantly mitigating the risk of cancer spread. Nonetheless, rehabilitation interventions for cancer metastasis encounter numerous hurdles, including individual variability, psychosocial conditions, and technological implementation. Each patient possesses distinct physiological traits, genetic origins, and immunological responses, necessitating the development of tailored intervention programs. Simultaneously, emphasis must be placed on psychological support and emotional management to mitigate the risk of metastasis. Moreover, technical advancements like artificial intelligence, big data analytics, and nanotechnology present novel opportunities for rehabilitation interventions; yet, their implementation necessitates proof of efficacy and resolution of accessibility challenges. Enhancing patient education and social support will facilitate improved rehabilitation adherence and mental well-being, thereby diminishing the likelihood of cancer cell metastasis.

Nevertheless, it should be acknowledged that patient responses to rehabilitation interventions are highly heterogeneous due to variations in tumor type, disease stage, and individual physical condition, which may affect generalizability. Additionally, logistical barriers such as limited access to specialized services and disparities in the availability of technological resources can restrict the implementation of these interventions in real-world settings. The increasing use of technology and digital tools in rehabilitation also raises ethical concerns regarding data privacy and equitable access, which warrant careful consideration in future applications and research. Future research should investigate the differential impacts of specific rehabilitation approaches on metastasis inhibition across various cancer types to elucidate optimal circumstances and strategies for rehabilitation intervention. Simultaneously, long-term follow-up studies are crucial for assessing the enduring effects of rehabilitative interventions, as they evaluate short-term efficacy and offer a scientific foundation for the long-term prevention of cancer recurrence and metastasis. Furthermore, comprehensive investigation into the molecular mechanisms underlying rehabilitation interventions, including their modulation of cytokines, immune cells, and matrix constituents within the TME, will furnish theoretical foundations for the formulation of more targeted rehabilitation strategies. These initiatives will facilitate the shift of rehabilitation medicine from conventional empirical approaches to mechanism-based precision medicine, thereby offering enhanced rehabilitation care for cancer patients and ultimately enhancing their long-term prognosis and quality of life.

Funding Statement

The author(s) declared that financial support was not received for this work and/or its publication.

Footnotes

Edited by: Irene Lidoriki, Harvard T H Chan School of Public Health Department of Environmental Health, United States

Reviewed by: Samson Peter Mvandal, Muhimbili National Hospital, Tanzania

Shazia Tahira, Bahria University, Pakistan

Author contributions

XC: Writing – review & editing, Writing – original draft. JZ: Writing – review & editing. XL: Supervision, Writing – review & editing, Conceptualization. HD: Supervision, Conceptualization, Writing – review & editing.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1. Elmadani M, Mokaya PO, Omer AAA, Kiptulon EK, Klara S, Orsolya M. Cancer burden in Europe: a systematic analysis of the GLOBOCAN database (2022). BMC Cancer. (2025) 25:447. doi:  10.1186/s12885-025-13862-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2021) 71:209–49. doi:  10.3322/caac.21660 [DOI] [PubMed] [Google Scholar]
  • 3. Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. (2010) 376:1186–93. doi:  10.1016/s0140-6736(10)61152-x [DOI] [PubMed] [Google Scholar]
  • 4. Wang Z, Tang P, Xiao H, Peng S, Chen J, Wang Y, et al. Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1-SNAI1 axis. J Pathol. (2024) 264:68–79. doi:  10.1002/path.6325 [DOI] [PubMed] [Google Scholar]
  • 5. Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. (2020) 5:28. doi:  10.1038/s41392-020-0134-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. (2017) 168:670–91. doi:  10.1016/j.cell.2016.11.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Khan SU, Fatima K, Malik F, Kalkavan H, Wani A. Cancer metastasis: molecular mechanisms and clinical perspectives. Pharmacol Ther. (2023) 250:108522. doi:  10.1016/j.pharmthera.2023.108522 [DOI] [PubMed] [Google Scholar]
  • 8. Pedersen L, Christensen JF, Hojman P. Effects of exercise on tumor physiology and metabolism. Cancer J. (2015) 21:111–6. doi:  10.1097/ppo.0000000000000096 [DOI] [PubMed] [Google Scholar]
  • 9. Hiensch AE, Depenbusch J, Schmidt ME, Monninkhof EM, Pelaez M, Clauss D, et al. Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial. Nat Med. (2024) 30:2957–66. doi:  10.1038/s41591-024-03143-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. (2007) 25:4396–404. doi:  10.1200/jco.2006.08.2024 [DOI] [PubMed] [Google Scholar]
  • 11. Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab. (2016) 23:554–62. doi:  10.1016/j.cmet.2016.01.011 [DOI] [PubMed] [Google Scholar]
  • 12. Liang ZQ, Bian Y, Gu JF, Yin G, Sun RL, Liang Y, et al. Exploring the anti-metastatic effects of Astragalus mongholicus Bunge-Curcuma aromatica Salisb. on colorectal cancer: a network-based metabolomics and pharmacology approach. Phytomedicine. (2023) 114:154772. doi:  10.1016/j.phymed.2023.154772 [DOI] [PubMed] [Google Scholar]
  • 13. Stout NL, Santa Mina D, Lyons KD, Robb K, Silver JK. A systematic review of rehabilitation and exercise recommendations in oncology guidelines. CA Cancer J Clin. (2021) 71:149–75. doi:  10.3322/caac.21639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Patel AV, Friedenreich CM, Moore SC, Hayes SC, Silver JK, Campbell KL, et al. American college of sports medicine roundtable report on physical activity, sedentary behavior, and cancer prevention and control. Med Sci Sports Exerc. (2019) 51:2391–402. doi:  10.1249/mss.0000000000002117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Cormie P, Zopf EM, Zhang X, Schmitz KH. The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects. Epidemiol Rev. (2017) 39:71–92. doi:  10.1093/epirev/mxx007 [DOI] [PubMed] [Google Scholar]
  • 16. Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. (2012) 2012:Cd008465. doi:  10.1002/14651858.CD008465.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. van Vulpen J, Sweegers M, Peeters PH, Newton RU, Aaronson NK, Courneya KS, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. (2017) 52:91–104. doi:  10.1016/j.ctrv.2016.11.010 [DOI] [PubMed] [Google Scholar]
  • 18. He A, Pu Y, Jia C, Wu M, He H, Xia Y. The influence of exercise on cancer risk, the tumor microenvironment and the treatment of cancer. Sports Med. (2024) 54:1371–97. doi:  10.1007/s40279-024-02031-2 [DOI] [PubMed] [Google Scholar]
  • 19. Luo Z, Mei J, Wang X, Wang R, He Z, Geffen Y, et al. Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment. Cell Rep. (2024) 43:114697. doi:  10.1016/j.celrep.2024.114697 [DOI] [PubMed] [Google Scholar]
  • 20. Puurand M, Llorente A, Linē A, Kaambre T. Exercise-induced extracellular vesicles in reprogramming energy metabolism in cancer. Front Oncol. (2024) 14:1480074. doi:  10.3389/fonc.2024.1480074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Casciano F, Caruso L, Zauli E, Gonelli A, Zauli G, Vaccarezza M. Emerging mechanisms of physical exercise benefits in adjuvant and neoadjuvant cancer immunotherapy. Biomedicines. (2024) 12(11):2528. doi:  10.3390/biomedicines12112528 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Feng Y, Feng X, Wan R, Luo Z, Qu L, Wang Q. Impact of exercise on cancer: mechanistic perspectives and new insights. Front Immunol. (2024) 15:1474770. doi:  10.3389/fimmu.2024.1474770 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Hussey C, Hanbridge M, Dowling M, Gupta A. Cancer survivorship: understanding the patients' journey and perspectives on post-treatment needs. BMC Sports Sci Med Rehabil. (2024) 16:82. doi:  10.1186/s13102-024-00864-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Garritson J, Krynski L, Haverbeck L, Haughian JM, Pullen NA, Hayward R. Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells. PloS One. (2020) 15:e0234548. doi:  10.1371/journal.pone.0234548 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Silva CT, Silva CK, Casonatto J, Carrasco AC, McVeigh JG, Cardoso JR. Effects of aquatic exercises in woman who have undergone surgery after breast cancer: a systematic review with meta-analysis. Braz J Phys Ther. (2025) 29:101230. doi:  10.1016/j.bjpt.2025.101230 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Danhauer SC, Addington EL, Cohen L, Sohl SJ, Van Puymbroeck M, Albinati NK, et al. Yoga for symptom management in oncology: a review of the evidence base and future directions for research. Cancer. (2019) 125:1979–89. doi:  10.1002/cncr.31979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Cramer H, Lange S, Klose P, Paul A, Dobos G. Yoga for breast cancer patients and survivors: a systematic review and meta-analysis. BMC Cancer. (2012) 12:412. doi:  10.1186/1471-2407-12-412 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Lin KY, Hu YT, Chang KJ, Lin HF, Tsauo JY. Effects of yoga on psychological health, quality of life, and physical health of patients with cancer: a meta-analysis. Evid Based Complement Alternat Med. (2011) 2011:659876. doi:  10.1155/2011/659876 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Pan H, Meng R, Jia Z, Zhang J, Ma W, Liu Y, et al. Exercise: a non-drug strategy of NK cell activation. Braz J Med Biol Res. (2024) 57:e14144. doi:  10.1590/1414-431X2024e14144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Santara SS, Lee D, Crespo Â, Hu JJ, Walker C, Ma X, et al. The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells. Nature. (2023) 616:348–56. doi:  10.1038/s41586-023-05912-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Sadhukhan P, Seiwert TY. The role of macrophages in the tumor microenvironment and tumor metabolism. Semin Immunopathol. (2023) 45:187–201. doi:  10.1007/s00281-023-00988-2 [DOI] [PubMed] [Google Scholar]
  • 32. Athanasiou N, Bogdanis GC, Mastorakos G. Endocrine responses of the stress system to different types of exercise. Rev Endocr Metab Disord. (2023) 24:251–66. doi:  10.1007/s11154-022-09758-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Abadi AJ, Mirzaei S, Mahabady MK, Hashemi F, Zabolian A, Hashemi F, et al. Curcumin and its derivatives in cancer therapy: potentiating antitumor activity of cisplatin and reducing side effects. Phytother Res. (2022) 36:189–213. doi:  10.1002/ptr.7305 [DOI] [PubMed] [Google Scholar]
  • 34. Castro-Espin C, Agudo A, Bonet C, Katzke V, Turzanski-Fortner R, Aleksandrova K, et al. Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study. Eur J Epidemiol. (2021) 36:953–64. doi:  10.1007/s10654-021-00772-2 [DOI] [PubMed] [Google Scholar]
  • 35. Farley MJ, Boytar AN, Adlard KN, Salisbury CE, Hart NH, Schaumberg MA, et al. Interleukin-15 and high-intensity exercise: relationship with inflammation, body composition and fitness in cancer survivors. J Physiol. (2024) 602:5203–15. doi:  10.1113/jp286043 [DOI] [PubMed] [Google Scholar]
  • 36. Hojman P, Gehl J, Christensen JF, Pedersen BK. Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. (2018) 27:10–21. doi:  10.1016/j.cmet.2017.09.015 [DOI] [PubMed] [Google Scholar]
  • 37. Idorn M, Hojman P. Exercise-dependent regulation of NK cells in cancer protection. Trends Mol Med. (2016) 22:565–77. doi:  10.1016/j.molmed.2016.05.007 [DOI] [PubMed] [Google Scholar]
  • 38. Alizadeh Zarei M, Seyed Hosseini E, Haddad Kashani H, Ahmad E, Nikzad H. Effects of the exercise-inducible myokine irisin on proliferation and Malignant properties of ovarian cancer cells through the HIF-1 α signaling pathway. Sci Rep. (2023) 13:170. doi:  10.1038/s41598-022-26700-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, et al. Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer: the EXTEND phase 2 randomized clinical trial. JAMA Oncol. (2023) 9:825–34. doi:  10.1001/jamaoncol.2023.0161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Tripathi GM, Misra UK, Kalita J, Singh VK, Tripathi A. Effect of exercise on β-endorphin and its receptors in myasthenia gravis patients. Mol Neurobiol. (2023) 60:3010–9. doi:  10.1007/s12035-023-03247-5 [DOI] [PubMed] [Google Scholar]
  • 41. Ueda H, Neyama H. Fibromyalgia animal models using intermittent cold and psychological stress. Biomedicines. (2023) 12(1):56. doi:  10.3390/biomedicines12010056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Bonanno FG. Management of hemorrhagic shock: physiology approach, timing and strategies. J Clin Med. (2022) 12(1):260. doi:  10.3390/jcm12010260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Yang Z, Su W, Wei X, Qu S, Zhao D, Zhou J, et al. HIF-1α drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep. (2023) 42:112945. doi:  10.1016/j.celrep.2023.112945 [DOI] [PubMed] [Google Scholar]
  • 44. Khalafi M, Symonds ME, Sakhaei MH, Ghasemi F. The effects of exercise training on circulating adhesion molecules in adults: a systematic review and meta-analysis. PloS One. (2023) 18:e0292734. doi:  10.1371/journal.pone.0292734 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Ma Y, Kroemer G. The cancer-immune dialogue in the context of stress. Nat Rev Immunol. (2024) 24:264–81. doi:  10.1038/s41577-023-00949-8 [DOI] [PubMed] [Google Scholar]
  • 46. Gao Y, Liu W, Liu P, Li M, Ni B. Effects of psychological stress on multiple sclerosis via HPA axis-mediated modulation of natural killer T cell activity. CNS Neurol Disord Drug Targets. (2024) 23:1450–62. doi:  10.2174/0118715273315953240528075542 [DOI] [PubMed] [Google Scholar]
  • 47. Yan J, Chen Y, Luo M, Hu X, Li H, Liu Q, et al. Chronic stress in solid tumor development: from mechanisms to interventions. J BioMed Sci. (2023) 30:8. doi:  10.1186/s12929-023-00903-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Zhu Z, Zhang X, Yan J, Wang M, Lv Y, Zhang W, et al. Chronic stress and cancer progression through neuro-endocrine-immune networks (review). Oncol Rep. (2026) 56(1):123. doi:  10.3892/or.2026.9128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Reininger KM, Biel HM, Hennig T, Zitzmann S, Weigel A, Spitzer C, et al. Beliefs about emotions predict psychological stress related to somatic symptoms. Br J Clin Psychol. (2023) 62:699–716. doi:  10.1111/bjc.12438 [DOI] [PubMed] [Google Scholar]
  • 50. Lorenz TK. Autonomic, endocrine, and psychological stress responses to different forms of blood draw. PloS One. (2021) 16:e0257110. doi:  10.1371/journal.pone.0257110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Gui H, Chen X, Li L, Zhu L, Jing Q, Nie Y, et al. Psychological distress influences lung cancer: Advances and perspectives on the immune system and immunotherapy. Int Immunopharmacol. (2023) 121:110251. doi:  10.1016/j.intimp.2023.110251 [DOI] [PubMed] [Google Scholar]
  • 52. Weis J. Psychosocial long-term effects of cancer. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. (2022) 65:431–8. doi:  10.1007/s00103-022-03506-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Crean-Tate KK, Faubion SS, Pederson HJ, Vencill JA, Batur P. Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy. Am J Obstet Gynecol. (2020) 222:103–13. doi:  10.1016/j.ajog.2019.08.043 [DOI] [PubMed] [Google Scholar]
  • 54. Gegechkori N, Haines L, Lin JJ. Long-term and latent side effects of specific cancer types. Med Clin North Am. (2017) 101:1053–73. doi:  10.1016/j.mcna.2017.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Salembier R, De Haes C, Bellemans J, Demeyere K, Van Den Broeck W, Sanders NN, et al. Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models. Breast Cancer Res. (2024) 26:63. doi:  10.1186/s13058-024-01815-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Possamai-Della T, Cararo JH, Aguiar-Geraldo JM, Peper-Nascimento J, Zugno AI, Fries GR, et al. Prenatal stress induces long-term behavioral sex-dependent changes in rats offspring: the role of the HPA axis and epigenetics. Mol Neurobiol. (2023) 60:5013–33. doi:  10.1007/s12035-023-03348-1 [DOI] [PubMed] [Google Scholar]
  • 57. Prete A, Bancos I. Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches. Nat Rev Endocrinol. (2024) 20:460–73. doi:  10.1038/s41574-024-00984-y [DOI] [PubMed] [Google Scholar]
  • 58. Cruceriu D, Baldasici O, Balacescu O, Berindan-Neagoe I. The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches. Cell Oncol (Dordr). (2020) 43:1–18. doi:  10.1007/s13402-019-00489-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Jassim GA, Doherty S, Whitford DL, Khashan AS. Psychological interventions for women with non-metastatic breast cancer. Cochrane Database Syst Rev. (2023) 1:Cd008729. doi:  10.1002/14651858.CD008729.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Wesarg-Menzel C, Marheinecke R, Staaks J, Engert V. Associations of diurnal cortisol parameters with cortisol stress reactivity and recovery: a systematic review and meta-analysis. Psychoneuroendocrinology. (2024) 163:106976. doi:  10.1016/j.psyneuen.2024.106976 [DOI] [PubMed] [Google Scholar]
  • 61. Liu Z, Lei M, Bai Y. Chronic stress mediates inflammatory cytokines alterations and its role in tumorigenesis. J Inflammation Res. (2025) 18:1067–90. doi:  10.2147/jir.S485159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Bisgaard TH, Allin KH, Keefer L, Ananthakrishnan AN, Jess T. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Rev Gastroenterol Hepatol. (2022) 19:717–26. doi:  10.1038/s41575-022-00634-6 [DOI] [PubMed] [Google Scholar]
  • 63. Alizadeh Pahlavani H. Possible role of exercise therapy on depression: Effector neurotransmitters as key players. Behav Brain Res. (2024) 459:114791. doi:  10.1016/j.bbr.2023.114791 [DOI] [PubMed] [Google Scholar]
  • 64. Badr S, Rezq S, Abdelghany RH. Endogenous β-endorphin plays a pivotal role in angiotensin II-mediated central neurochemical changes and pressor response. Chem Biol Interact. (2021) 342:109475. doi:  10.1016/j.cbi.2021.109475 [DOI] [PubMed] [Google Scholar]
  • 65. Pilozzi A, Carro C, Huang X. Roles of β-endorphin in stress, behavior, neuroinflammation, and brain energy metabolism. Int J Mol Sci. (2020) 22(1):338. doi:  10.3390/ijms22010338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Chen Z, Gu J, Lin S, Xu Z, Xu H, Zhao J, et al. Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway. J Ethnopharmacol. (2023) 300:115719. doi:  10.1016/j.jep.2022.115719 [DOI] [PubMed] [Google Scholar]
  • 67. Ren M, Kong J, Luan C, Mu Y. The role of depression in the progression of tumor cell inflammation and the potential regulatory mechanisms of aerobic exercise: a narrative review from molecular and cellular perspectives. Front Psychiatry. (2025) 16:1683058. doi:  10.3389/fpsyt.2025.1683058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Shahid W, Noor R, Bashir MS. Effects of exercise on sex steroid hormones (estrogen, progesterone, testosterone) in eumenorrheic females: a systematic to review and meta-analysis. BMC Womens Health. (2024) 24:354. doi:  10.1186/s12905-024-03203-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Shen H, Zhang T, Yang H, Lai Z, Zhou W, Mei J, et al. Ovarian hormones-autophagy-immunity axis in menstruation and endometriosis. Theranostics. (2021) 11:3512–26. doi:  10.7150/thno.55241 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Zhang C, Ge Z, Zhou H, Wei M, Ding X, Lin Z, et al. Sex chromosomes/hormones and the tumor microenvironment of non-reproductive cancers. Front Immunol. (2025) 16:1642956. doi:  10.3389/fimmu.2025.1642956 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Napolitano F, Wang Y, Sudhan DR, Gonzalez-Ericsson PI, Formisano L, Unni N, et al. CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer. J Clin Invest. (2026) 136(3):e188458. doi:  10.1172/jci188458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Idorn M, Thor Straten P. Exercise and cancer: from "healthy" to "therapeutic"? Cancer Immunol Immunother. (2017) 66:667–71. doi:  10.1007/s00262-017-1985-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Wilson RL, Newton RU, Taaffe DR, Hart NH, Lyons-Wall P, Galvão DA. Weight loss for obese prostate cancer patients on androgen deprivation therapy. Med Sci Sports Exerc. (2021) 53:470–8. doi:  10.1249/mss.0000000000002509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Kissow J, Jacobsen KJ, Gunnarsson TP, Jessen S, Hostrup M. Effects of follicular and luteal phase-based menstrual cycle resistance training on muscle strength and mass. Sports Med. (2022) 52:2813–9. doi:  10.1007/s40279-022-01679-y [DOI] [PubMed] [Google Scholar]
  • 75. Kong X, Gao R, Wang Z, Wang X, Fang Y, Gao J, et al. Melatonin: a potential therapeutic option for breast cancer. Trends Endocrinol Metab. (2020) 31:859–71. doi:  10.1016/j.tem.2020.08.001 [DOI] [PubMed] [Google Scholar]
  • 76. Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, Sweeney FC, et al. Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial. Breast Cancer Res. (2018) 20:124. doi:  10.1186/s13058-018-1051-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Koivula T, Lempiäinen S, Rinne P, Hollmén M, Sundberg CJ, Rundqvist H, et al. Acute exercise mobilizes CD8(+) cytotoxic T cells and NK cells in lymphoma patients. Front Physiol. (2022) 13:1078512. doi:  10.3389/fphys.2022.1078512 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Smith KJ, Ainslie PN. Regulation of cerebral blood flow and metabolism during exercise. Exp Physiol. (2017) 102:1356–71. doi:  10.1113/ep086249 [DOI] [PubMed] [Google Scholar]
  • 79. Chang K, Wu W, Chen Y, Chen L, Hsu W, Lin Y, et al. Enhanced serum levels of tumor necrosis factor-α, interleukin-1β, and -6 in sarcopenia: alleviation through exercise and nutrition intervention. Aging (Albany NY). (2023) 15:13471–85. doi:  10.18632/aging.205254 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Bettariga F, Taaffe DR, Crespo-Garcia C, Clay TD, De Santi M, Baldelli G, et al. Effects of resistance versus high-intensity interval training on myokines and cancer cell suppression in breast cancer survivors: a randomized trial. Med Sci Sports Exerc. (2026) 58:1–9. doi:  10.1249/mss.0000000000003848 [DOI] [PubMed] [Google Scholar]
  • 81. Natarajan A, Pradhan R, Dieterich W, Schwappacher R, Reljic D, Herrmann HJ, et al. The influence of physical training on breast cancer: the role of exercise-induced myokines in regulating breast cancer cell growth and survival. Int J Mol Sci. (2024) 25(21):11379. doi:  10.3390/ijms252111379 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Díez-Fernández DM, Esteban-Simón A, Baena-Raya A, Pérez-Castilla A, Rodríguez-Pérez MA, Soriano-Maldonado A. Optimizing resistance training intensity in supportive care for survivors of breast cancer: velocity-based approach in the row exercise. Support Care Cancer. (2024) 32:617. doi:  10.1007/s00520-024-08824-5 [DOI] [PubMed] [Google Scholar]
  • 83. Orange ST, Leslie J, Ross M, Mann DA, Wackerhage H. The exercise IL-6 enigma in cancer. Trends Endocrinol Metab. (2023) 34:749–63. doi:  10.1016/j.tem.2023.08.001 [DOI] [PubMed] [Google Scholar]
  • 84. Chen X, Li Z, Zhang J. A novel approach to cancer rehabilitation: assessing the influence of exercise intervention on postoperative recovery and survival rates. Int J Surg. (2025) 111(5):3373–85. doi:  10.1097/JS9.0000000000002323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Batalik L, Chamradova K, Winnige P, Dosbaba F, Batalikova K, Vlazna D, et al. Effect of exercise-based cancer rehabilitation via telehealth: a systematic review and meta-analysis. BMC Cancer. (2024) 24:600. doi:  10.1186/s12885-024-12348-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. de Sire A, Losco L, Lippi L, Spadoni D, Kaciulyte J, Sert G, et al. Surgical treatment and rehabilitation strategies for upper and lower extremity lymphedema: a comprehensive review. Med (Kaunas). (2022) 58(7):954. doi:  10.3390/medicina58070954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Kotte M, Bolam KA, Mijwel S, Altena R, Cormie P, Wengström Y. Distance-based delivery of exercise for people treated for breast, prostate or colorectal cancer: a study protocol for a randomised controlled trial of EX-MED Cancer Sweden. Trials. (2023) 24:116. doi:  10.1186/s13063-023-07152-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Zhang H, Zhang Y, Luo F, Wen Y, Ni J, Wang J. Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients-a systematic review and meta-analysis. Front Nutr. (2025) 12:1612674. doi:  10.3389/fnut.2025.1612674 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Felser S, Rogahn J, Glass Ä, Bonke LA, Strüder DF, Stolle J, et al. Feasibility of individualized home exercise programs for patients with head and neck cancer-study protocol and first results of a multicentre single-arm intervention trial (OSHO #94). PloS One. (2024) 19:e0301304. doi:  10.1371/journal.pone.0301304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Messer S, Oeser A, Wagner C, Wender A, Cryns N, Scherer RW, et al. Yoga for fatigue in people with cancer. Cochrane Database Syst Rev. (2025) 5:Cd015520. doi:  10.1002/14651858.Cd015520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Thomsen SN, Wriedt E, Stærk MG, Djurhuus SS, Toft BG, Wielsøe S, et al. Impact of exercise training on tumour-infiltrating T cells in human prostate cancer: A secondary analysis of a randomized controlled trial (PRO-TEST). Exp Physiol. (2025) 111(6):3000–09. doi:  10.1113/EP092374 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Kurz E, Hirsch CA, Dalton T, Shadaloey SA, Khodadadi-Jamayran A, Miller G, et al. Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer. Cancer Cell. (2022) 40:720–737.e5. doi:  10.1016/j.ccell.2022.05.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93. Qi F, Bao Q, Hu P, Guo Y, Yan Y, Yao X, et al. Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer therapy. Biomaterials. (2024) 307:122514. doi:  10.1016/j.biomaterials.2024.122514 [DOI] [PubMed] [Google Scholar]
  • 94. Chiang CF, Wang ZZ, Hsu YH, Miaw SC, Lin WL. Exercise improves the outcome of anticancer treatment with ultrasound-hyperthermia-enhanced nanochemotherapy and autophagy inhibitor. PloS One. (2023) 18:e0288380. doi:  10.1371/journal.pone.0288380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Isanejad A, Nazari S, Gharib B, Motlagh AG. Comparison of the effects of high-intensity interval and moderate-intensity continuous training on inflammatory markers, cardiorespiratory fitness, and quality of life in breast cancer patients. J Sport Health Sci. (2023) 12:674–89. doi:  10.1016/j.jshs.2023.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96. Vujadinovic ST, Ilic N, Selakovic I, Nedeljkovic U, Krstic N, Mujovic N, et al. TENS improves cisplatin-induced neuropathy in lung cancer patients. Med (Kaunas). (2022) 58(10):1405. doi:  10.3390/medicina58101405 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Ozalevli S, Ilgin D, Kul Karaali H, Bulac S, Akkoclu A. The effect of in-patient chest physiotherapy in lung cancer patients. Support Care Cancer. (2010) 18:351–8. doi:  10.1007/s00520-009-0659-6 [DOI] [PubMed] [Google Scholar]
  • 98. Church DD, Schwarz NA, Spillane MB, McKinley-Barnard SK, Andre TL, Ramirez AJ, et al. l-Leucine increases skeletal muscle IGF-1 but does not differentially increase Akt/mTORC1 signaling and serum IGF-1 compared to ursolic acid in response to resistance exercise in resistance-trained men. J Am Coll Nutr. (2016) 35:627–38. doi:  10.1080/07315724.2015.1132019 [DOI] [PubMed] [Google Scholar]
  • 99. Sartori R, Romanello V, Sandri M. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat Commun. (2021) 12:330. doi:  10.1038/s41467-020-20123-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Tian J, Wei T, Wei Y, Xiao F, He X, Lin K, et al. Effect of whole body vibration therapy in the rat model of steroid-induced osteonecrosis of the femoral head. Front Cell Dev Biol. (2023) 11:1251634. doi:  10.3389/fcell.2023.1251634 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Panciera T, Azzolin L, Cordenonsi M, Piccolo S. Mechanobiology of YAP and TAZ in physiology and disease. Nat Rev Mol Cell Biol. (2017) 18:758–70. doi:  10.1038/nrm.2017.87 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102. Edwards JJ, Coleman DA, Ritti-Dias RM, Farah BQ, Stensel DJE, Lucas SJE, et al. Isometric exercise training and arterial hypertension: An updated review. Sports Med. (2024) 54:1459–97. doi:  10.1007/s40279-024-02036-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Finch L, Frankel D, Gallant B, Landa C, Snyder N, Wilson R, et al. Occupational therapy in pulmonary rehabilitation programs: A scoping review. Respir Med. (2022) 199:106881. doi:  10.1016/j.rmed.2022.106881 [DOI] [PubMed] [Google Scholar]
  • 104. Hogan LM, Björklund Carlstedt A, Wagman P. Occupational therapy and stress-related exhaustion - a scoping review. Scand J Occup Ther. (2023) 30:1047–63. doi:  10.1080/11038128.2023.2207802 [DOI] [PubMed] [Google Scholar]
  • 105. Moorthy A, Eochagáin AN, Buggy DJ. Can acute postoperative pain management after tumour resection surgery modulate risk of later recurrence or metastasis? Front Oncol. (2021) 11:802592. doi:  10.3389/fonc.2021.802592 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106. Li Z, Feiyue Z, Gaofeng L. Traditional Chinese medicine and lung cancer--from theory to practice. BioMed Pharmacother. (2021) 137:111381. doi:  10.1016/j.biopha.2021.111381 [DOI] [PubMed] [Google Scholar]
  • 107. Yang J, Wahner-Roedler DL, Zhou X, Johnson LA, Do A, Pachman DR, et al. Acupuncture for palliative cancer pain management: Systematic review. BMJ Support Palliat Care. (2021) 11:264–70. doi:  10.1136/bmjspcare-2020-002638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108. Lv Z, Liu R, Su K, Gu Y, Fang L, Fan Y, et al. Acupuncture ameliorates breast cancer-related fatigue by regulating the gut microbiota-gut-brain axis. Front Endocrinol (Lausanne). (2022) 13:921119. doi:  10.3389/fendo.2022.921119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109. Yang H, Zhang J, Ling J. The modulatory effects and targets prediction of herbal medicines or phytochemicals on cancer immunosurveillance. Am J Chin Med. (2022) 50:1401–22. doi:  10.1142/s0192415x22500604 [DOI] [PubMed] [Google Scholar]
  • 110. Niu X, Wu T, Zeng L, Wang F, Lv W, Zhang L, et al. Chronic stress in cancer development and progression. Sci Bull (Beijing). (2025) 70:3885–907. doi:  10.1016/j.scib.2025.09.034 [DOI] [PubMed] [Google Scholar]
  • 111. Simon NM, Hofmann SG, Rosenfield D, Hoeppner SS, Hoge EA, Bui E, et al. Efficacy of yoga vs cognitive behavioral therapy vs stress education for the treatment of generalized anxiety disorder: A randomized clinical trial. JAMA Psychiatry. (2021) 78:13–20. doi:  10.1001/jamapsychiatry.2020.2496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112. Tian X, Yi L, Liang C, Gu L, Peng C, Chen G, et al. The impact of mindfulness-based stress reduction (MBSR) on psychological outcomes and quality of life in patients with lung cancer: A meta-analysis. Front Psychol. (2022) 13:901247. doi:  10.3389/fpsyg.2022.901247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113. Takemura N, Cheung DST, Fong DYT, Lee AWM, Lam T, Ho JC, et al. Effectiveness of aerobic exercise and Tai Chi interventions on sleep quality in patients with advanced lung cancer: A randomized clinical trial. JAMA Oncol. (2024) 10:176–84. doi:  10.1001/jamaoncol.2023.5248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114. Houben LHP, Overkamp M, Van Kraaij P, Trommelen J, Van Roermund JGH, De Vries P, et al. Resistance exercise training increases muscle mass and strength in prostate cancer patients on androgen deprivation therapy. Med Sci Sports Exerc. (2023) 55:614–24. doi:  10.1249/mss.0000000000003095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115. Herranz‐Gómez A, Cuenca‐Martínez F, Suso‐Martí L, Varangot‐Reille C, Calatayud J, Blanco‐Díaz M, et al. Effectiveness of HIIT in patients with cancer or cancer survivors: An umbrella and mapping review with meta-meta-analysis. Scand J Med Sci Sports. (2022) 32:1522–49. doi:  10.1111/sms.14223 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116. Ohno S, Sumiyoshi Y, Mori M, Sugimachi K. Hyperthermia for rectal cancer. Surgery. (2002) 131:S121–127. doi:  10.1067/msy.2002.119363 [DOI] [PubMed] [Google Scholar]
  • 117. Hurlow A, Bennett MI, Robb KA, Johnson MI, Simpson KH, Oxberry SG. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev. (2012) 2012:Cd006276. doi:  10.1002/14651858.CD006276.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118. Baker MK, Peddle-McIntyre CJ, Galvão DA, Hunt C, Spry N, Newton RU. Whole body vibration exposure on markers of bone turnover, body composition, and physical functioning in breast cancer patients receiving aromatase inhibitor therapy: A randomized controlled trial. Integr Cancer Ther. (2018) 17:968–78. doi:  10.1177/1534735418781489 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119. Zhang H. Cancer pain management-new therapies. Curr Oncol Rep. (2022) 24:223–6. doi:  10.1007/s11912-021-01166-z [DOI] [PubMed] [Google Scholar]
  • 120. Hamidi H, Ivaska J. Every step of the way: Integrins in cancer progression and metastasis. Nat Rev Cancer. (2018) 18:533–48. doi:  10.1038/s41568-018-0038-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121. Bae CR, Gelvosa MN, Jeon JY. Rehabilitation in advanced cancer patients with bone metastases and neural compromise: Current status and future directions. Curr Oncol Rep. (2022) 24:1023–33. doi:  10.1007/s11912-022-01229-9 [DOI] [PubMed] [Google Scholar]
  • 122. Campbell KL, Cormie P, Weller S, Alibhai SMH, Bolam KA, Campbell A, et al. Exercise recommendation for people with bone metastases: Expert consensus for health care providers and exercise professionals. JCO Oncol Pract. (2022) 18:e697–709. doi:  10.1200/op.21.00454 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123. Sheill G, Guinan EM, Peat N, Hussey J. Considerations for exercise prescription in patients with bone metastases: A comprehensive narrative review. Pm R. (2018) 10:843–64. doi:  10.1016/j.pmrj.2018.02.006 [DOI] [PubMed] [Google Scholar]
  • 124. Weller S, Hart NH, Bolam KA, Mansfield S, Mina DS, Winters-Stone KM, et al. Exercise for individuals with bone metastases: A systematic review. Crit Rev Oncol Hematol. (2021) 166:103433. doi:  10.1016/j.critrevonc.2021.103433 [DOI] [PubMed] [Google Scholar]
  • 125. Li Z, Xia Q, He Y, Li L, Yin P. MDSCs in bone metastasis: Mechanisms and therapeutic potential. Cancer Lett. (2024) 592:216906. doi:  10.1016/j.canlet.2024.216906 [DOI] [PubMed] [Google Scholar]
  • 126. Skrajnowska D, Jagielska A, Ruszczyńska A, Wagner B, Bielecki W, Bobrowska-Korczak B. Title changes in the mineral composition of rat femoral bones induced by implantation of LNCaP prostate cancer cells and dietary supplementation. Nutrients. (2020) 13(1):100. doi:  10.3390/nu13010100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127. Cavalheri V, Granger CL. Exercise training as part of lung cancer therapy. Respirology. (2020) 25:80–7. doi:  10.1111/resp.13869 [DOI] [PubMed] [Google Scholar]
  • 128. Chang P, Lin C, Lee Y, Liu Y, Chang G, Hoogland AI, et al. Exercise experiences in patients with metastatic lung cancer: A qualitative approach. PloS One. (2020) 15:e0230188. doi:  10.1371/journal.pone.0230188 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129. Rosenzweig KE, Gomez JE. Concurrent chemotherapy and radiation therapy for inoperable locally advanced non-small-cell lung cancer. J Clin Oncol. (2017) 35:6–10. doi:  10.1200/jco.2016.69.9678 [DOI] [PubMed] [Google Scholar]
  • 130. Wan R, Chen Y, Feng X, Luo Z, Peng Z, Qi B, et al. Exercise potentially prevents colorectal cancer liver metastases by suppressing tumor epithelial cell stemness via RPS4X downregulation. Heliyon. (2024) 10:e26604. doi:  10.1016/j.heliyon.2024.e26604 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131. Castillo-Pichardo L, Martínez-Montemayor MM, Martínez JE, Wall KM, Cubano LA, Dharmawardhane S. Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clin Exp Metastasis. (2009) 26:505–16. doi:  10.1007/s10585-009-9250-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132. Yazdani HO, Kaltenmeier C, Morder K, Moon J, Traczek M, Loughran P, et al. Exercise training decreases hepatic injury and metastases through changes in immune response to liver ischemia/reperfusion in mice. Hepatology. (2021) 73:2494–509. doi:  10.1002/hep.31552 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133. Wang D, Yang H, Liu X, Chen Z, Wang Y, Fong WP, et al. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases. Theranostics. (2021) 11:7018–28. doi:  10.7150/thno.59644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134. Fountain DM, Burke GA. Multidisciplinary rehabilitation for children with brain tumors: A systematic review. Dev Neurorehabil. (2017) 20:68–75. doi:  10.3109/17518423.2015.1065017 [DOI] [PubMed] [Google Scholar]
  • 135. Campbell KL, Zadravec K, Bland KA, Chesley E, Wolf F, Janelsins MC. The effect of exercise on cancer-related cognitive impairment and applications for physical therapy: Systematic review of randomized controlled trials. Phys Ther. (2020) 100:523–42. doi:  10.1093/ptj/pzz090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136. Perkins A, Liu G. Primary brain tumors in adults: Diagnosis and treatment. Am Fam Physician. (2016) 93:211–7. [PubMed] [Google Scholar]
  • 137. Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, et al. Cancer-related cognitive impairment: An update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol. (2019) 30:1925–40. doi:  10.1093/annonc/mdz410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138. Virgen CG, Kelkar N, Tran A, Rosa CM, Cruz-Topete D, Amatya S, et al. Pharmacological management of cancer pain: Novel therapeutics. BioMed Pharmacother. (2022) 156:113871. doi:  10.1016/j.biopha.2022.113871 [DOI] [PubMed] [Google Scholar]
  • 139. Feng X, Hong T, Liu W, Xu C, Li W, Yang B, et al. Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma. Front Endocrinol (Lausanne). (2022) 13:1054358. doi:  10.3389/fendo.2022.1054358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the International Society of Lymphology. Lymphology. (2020) 53:3–19. doi:  10.2458/lymph.4649 [DOI] [PubMed] [Google Scholar]
  • 141. Chan DN, Lui LY, So WK. Effectiveness of exercise programmes on shoulder mobility and lymphoedema after axillary lymph node dissection for breast cancer: Systematic review. J Adv Nurs. (2010) 66:1902–14. doi:  10.1111/j.1365-2648.2010.05374.x [DOI] [PubMed] [Google Scholar]
  • 142. Bowman C, Rockson SG. The role of inflammation in lymphedema: A narrative review of pathogenesis and opportunities for therapeutic intervention. Int J Mol Sci. (2024) 25(7):3907. doi:  10.3390/ijms25073907 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143. Xue L, Jiang Y, Guo Y, Ma H, Jiang L, Wang X, et al. Serum IL-6, IL-10, TNF-a changes in postpartum perineal oedema rehabilitation. J Med Biochem. (2025) 44:831–9. doi:  10.5937/jomb0-56599 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144. Hou Y, Wu J, Yang S, Wang H, Wang X, Lu Z, et al. The spinal lymphatic system: An emerging pathway bridging fluid homeostasis, immunity, and disease. Bone Res. (2026) 14(1):28. doi:  10.1038/s41413-026-00508-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145. Ugurel S, Enk A. Skin cancer: Follow-up, rehabilitation, palliative and supportive care. J Dtsch Dermatol Ges. (2008) 6:492–8. doi:  10.1111/j.1610-0387.2008.06675.x [DOI] [PubMed] [Google Scholar]
  • 146. Zhao Y, Yu C, Zhang J, Yao Q, Zhu X, Zhou X. The gut-skin axis: Emerging insights in understanding and treating skin diseases through gut microbiome modulation (review). Int J Mol Med. (2025) 56(6):210. doi:  10.3892/ijmm.2025.5651 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147. Sevcikova A, Mladosievicova B, Mego M, Ciernikova S. Exploring the role of the gut and intratumoral microbiomes in tumor progression and metastasis. Int J Mol Sci. (2023) 24(24):17199. doi:  10.3390/ijms242417199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148. Melough MM, Chun OK. Dietary furocoumarins and skin cancer: A review of current biological evidence. Food Chem Toxicol. (2018) 122:163–71. doi:  10.1016/j.fct.2018.10.027 [DOI] [PubMed] [Google Scholar]
  • 149. Mellette SJ. Cancer rehabilitation. J Natl Cancer Inst. (1993) 85:781–4. doi:  10.1093/jnci/85.10.781 [DOI] [PubMed] [Google Scholar]
  • 150. Fong DYT, Ho JWC, Hui BPH, Lee AM, Macfarlane DJ, Leung SSK, et al. Physical activity for cancer survivors: Meta-analysis of randomised controlled trials. Bmj. (2012) 344:e70. doi:  10.1136/bmj.e70 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151. Schmitz KH, Campbell AM, Stuiver MM, Pinto BM, Schwartz AL, Morris GS, et al. Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer. CA Cancer J Clin. (2019) 69:468–84. doi:  10.3322/caac.21579 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152. Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: Consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. (2019) 51:2375–90. doi:  10.1249/mss.0000000000002116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153. Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, et al. Clinical Oncology Society of Australia position statement on exercise in cancer care. Med J Aust. (2018) 209:184–7. doi:  10.5694/mja18.00199 [DOI] [PubMed] [Google Scholar]
  • 154. Ostberg JR, Repasky EA. Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother. (2006) 55:292–8. doi:  10.1007/s00262-005-0689-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155. Kaye AD, Allen KE, Shah SS, Smith SA, Plaisance TR, Brouillette AE, et al. Efficacy of transcutaneous electrical nerve stimulation in management of cancer pain: a meta analysis. Curr Pain Headache Rep. (2025) 29:5. doi:  10.1007/s11916-024-01337-0 [DOI] [PubMed] [Google Scholar]
  • 156. Oh B, Butow PN, Mullan BA, Clarke SJ, Beale PJ, Pavlakis N, et al. Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Support Care Cancer. (2012) 20:1235–42. doi:  10.1007/s00520-011-1209-6 [DOI] [PubMed] [Google Scholar]
  • 157. Parke SC, Ng A, Martone P, Gerber LH, Zucker DS, Engle J, et al. Translating 2019 ACSM cancer exercise recommendations for a physiatric practice: Derived recommendations from an international expert panel. Pm R. (2022) 14:996–1009. doi:  10.1002/pmrj.12664 [DOI] [PubMed] [Google Scholar]
  • 158. Pluchino LA, D'Amico TA. National Comprehensive Cancer Network guidelines: Who makes them? What are they? Why are they important? Ann Thorac Surg. (2020) 110:1789–95. doi:  10.1016/j.athoracsur.2020.03.022 [DOI] [PubMed] [Google Scholar]
  • 159. Jordan K, Aapro M, Kaasa S, Ripamonti C, Scotté F, Strasser F, et al. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol. (2018) 29:36–43. doi:  10.1093/annonc/mdx757 [DOI] [PubMed] [Google Scholar]
  • 160. Kuderer NM, Desai A, Lustberg MB, Lyman GH. Mitigating acute chemotherapy-associated adverse events in patients with cancer. Nat Rev Clin Oncol. (2022) 19:681–97. doi:  10.1038/s41571-022-00685-3 [DOI] [PubMed] [Google Scholar]
  • 161. Ligibel JA, Bohlke K, May AM, Clinton SK, Demark-Wahnefried W, Gilchrist SC, et al. Exercise, diet, and weight management during cancer treatment: ASCO guideline. J Clin Oncol. (2022) 40:2491–507. doi:  10.1200/jco.22.00687 [DOI] [PubMed] [Google Scholar]
  • 162. Colombage UN, Ackerman IN, Parry SM, Granger CL, Nguyen T, Hill KD, et al. Prevalence and incidence of falls in older adults with cancer: a systematic review with meta-analysis. J Cancer Surviv. (2025). doi:  10.1007/s11764-025-01796-3 [DOI] [PubMed] [Google Scholar]
  • 163. Christou AI, Kalfadeli G, Bacopoulou F. Developmental foundations of psychosocial interventions in pediatric oncology: A lifespan framework for resilience. Children (Basel). (2026) 13(2):198. doi:  10.3390/children13020198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164. Christou AI, Kalfadeli G, Tsermentseli S, Bacopoulou F. Neurocognitive and emotional outcomes in childhood cancer: A developmental perspective. Curr Oncol. (2025) 3232(11):611. doi:  10.3390/curroncol32110611 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165. Cook S, Alibhai S, Mehta R, Savard M, Mariano C, LeBlanc D, et al. Improving care for older adults with cancer in Canada: A call to action. Curr Oncol. (2024) 31:3783–97. doi:  10.3390/curroncol31070279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166. Pergolotti M, Deal AM, Williams GR, Bryant AL, McCarthy L, Nyrop KA, et al. Older adults with cancer: A randomized controlled trial of occupational and physical therapy. J Am Geriatr Soc. (2019) 67:953–60. doi:  10.1111/jgs.15930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167. De Camilli A, Fischer G. Novel cellular and immunotherapy: Toxicities and perioperative implications. Curr Oncol. (2023) 30:7638–53. doi:  10.3390/curroncol30080554 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168. Pergolotti M, Williams GR, Campbell C, Munoz LA, Muss HB. Occupational therapy for adults with cancer: Why it matters. Oncologist. (2016) 21:314–9. doi:  10.1634/theoncologist.2015-0335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169. Poort H, Peters M, van der Graaf W, Nieuwkerk P, van de Wouw A, der Sanden MN, et al. Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: a randomized controlled trial. Ann Oncol. (2020) 31:115–22. doi:  10.1016/j.annonc.2019.09.002 [DOI] [PubMed] [Google Scholar]
  • 170. Rodríguez‐Cañamero S, Cobo‐Cuenca AI, Carmona‐Torres JM, Pozuelo‐Carrascosa DP, Santacruz‐Salas E, Rabanales‐Sotos JA, et al. Impact of physical exercise in advanced-stage cancer patients: Systematic review and meta-analysis. Cancer Med. (2022) 11:3714–27. doi:  10.1002/cam4.4746 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171. Taylor S, Keesing S, Wallis A, Russell B, Smith A, Grant R. Occupational therapy intervention for cancer patients following hospital discharge: How and when should we intervene? A systematic review. Aust Occup Ther J. (2021) 68:546–62. doi:  10.1111/1440-1630.12750 [DOI] [PubMed] [Google Scholar]
  • 172. Hwang NK, Jung YJ, Park JS. Information and communications technology-based telehealth approach for occupational therapy interventions for cancer survivors: A systematic review. Healthcare (Basel). (2020) 8(4):355. doi:  10.3390/healthcare8040355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 173. Kowalski L, Krusen NE. Lung cancer screening policy in Alaska and occupational therapy. Am J Occup Ther. (2021) 75(3):7503090010. doi:  10.5014/ajot.2021.048231 [DOI] [PubMed] [Google Scholar]
  • 174. Rauch A, Cieza A, Stucki G. How to apply the International Classification of Functioning, Disability and Health (ICF) for rehabilitation management in clinical practice. Eur J Phys Rehabil Med. (2008) 44:329–42. [PubMed] [Google Scholar]
  • 175. Jamshidi F, Farzad M, MacDermid JC, Varahra A, Hosseini SA, Asgarabad MH. Assessing the content based on ICF and quality based on COSMIN criteria of patient-reported outcome measures of functioning in breast cancer survivors: a systematic review. Breast Cancer. (2022) 29:377–93. doi:  10.1007/s12282-022-01340-6 [DOI] [PubMed] [Google Scholar]
  • 176. Pinto M, Calafiore D, Piccirillo MC, Costa M, Taskiran OO, de Sire A. Breast cancer survivorship: The role of rehabilitation according to the International Classification of Functioning Disability and Health-a scoping review. Curr Oncol Rep. (2022) 24:1163–75. doi:  10.1007/s11912-022-01262-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 177. Alt Murphy M, Murphy S, Persson HC, Bergström UB, Sunnerhagen KS. Kinematic Analysis Using 3D Motion Capture of Drinking Task in People With and Without Upper-extremity Impairments. J Vis Exp. (2018) 133:57228. doi:  10.3791/57228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178. Ohtake PJ, Lee AC, Scott JC, Hinman RS, Ali NA, Hinkson CR, et al. Physical impairments associated with post-intensive care syndrome: Systematic review based on the World Health Organization's International Classification of Functioning, Disability and Health framework. Phys Ther. (2018) 98:631–45. doi:  10.1093/ptj/pzy059 [DOI] [PubMed] [Google Scholar]
  • 179. Larsson-Lund M, Nyman A. Participation and occupation in occupational therapy models of practice: A discussion of possibilities and challenges. Scand J Occup Ther. (2017) 24:393–7. doi:  10.1080/11038128.2016.1267257 [DOI] [PubMed] [Google Scholar]
  • 180. Chen Y, Yeh Y, Wang C, Lin H, Lin C, Hsien H, et al. Cost utility analysis of multidisciplinary postacute care for stroke: A prospective six-hospital cohort study. Front Cardiovasc Med. (2022) 9:826898. doi:  10.3389/fcvm.2022.826898 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 181. Chiu C, Wang J, Hung C, Lin H, Hsien H, Hung K, et al. Impact of multidisciplinary stroke post-acute care on cost and functional status: A prospective study based on propensity score matching. Brain Sci. (2021) 11(2):161. doi:  10.3390/brainsci11020161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 182. Dominguez LJ, Veronese N, Vernuccio L, Catanese G, Inzerillo F, Salemi G, et al. Nutrition, physical activity, and other lifestyle factors in the prevention of cognitive decline and dementia. Nutrients. (2021) 13(11):4080. doi:  10.3390/nu13114080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 183. Tabesh MR, Eghtesadi M, Abolhasani M, Maleklou F, Ejtehadi F, Alizadeh Z. Nutrition, physical activity, and prescription of supplements in pre- and post-bariatric surgery patients: An updated comprehensive practical guideline. Obes Surg. (2023) 33:2557–72. doi:  10.1007/s11695-023-06703-2 [DOI] [PubMed] [Google Scholar]
  • 184. Nunes EA, Colenso‐Semple L, McKellar SR, Yau T, Ali MU, Fitzpatrick‐Lewis D, et al. Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adults. J Cachexia Sarcopenia Muscle. (2022) 13:795–810. doi:  10.1002/jcsm.12922 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185. Yang W, Hsieh H, Chen J, Tsai S, Chiu H, Chung M, et al. Efficacy and safety of a high-energy, low-protein formula replacement meal for pre-dialysis chronic kidney disease patients: A randomized controlled trial. Nutrients. (2023) 15(21):4506. doi:  10.3390/nu15214506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 186. Lovegrove JA. Dietary fats and cardiometabolic health-from public health to personalised nutrition: 'One for all' and 'all for one'. Nutr Bull. (2025) 50:132–41. doi:  10.1111/nbu.12722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187. Tyagi SC, Joshua IG. Exercise and nutrition in myocardial matrix metabolism, remodeling, regeneration, epigenetics, microcirculation, and muscle. Can J Physiol Pharmacol. (2014) 92:521–3. doi:  10.1139/cjpp-2014-0197 [DOI] [PubMed] [Google Scholar]
  • 188. Bordbar MR, Haghpanah S, Dabbaghmanesh MH, Omrani GR, Saki F. Bone mineral density in children with acute leukemia and its associated factors in Iran: a case-control study. Arch Osteoporos. (2016) 11:36. doi:  10.1007/s11657-016-0290-3 [DOI] [PubMed] [Google Scholar]
  • 189. Hernández-Camacho JD, Vicente-García C, Parsons DS, Navas-Enamorado I. Zinc at the crossroads of exercise and proteostasis. Redox Biol. (2020) 35:101529. doi:  10.1016/j.redox.2020.101529 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 190. Hoshino J. Renal rehabilitation: Exercise intervention and nutritional support in dialysis patients. Nutrients. (2021) 13(5):1444. doi:  10.3390/nu13051444 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 191. Moisey LL, Merriweather JL, Drover JW. The role of nutrition rehabilitation in the recovery of survivors of critical illness: underrecognized and underappreciated. Crit Care. (2022) 26:270. doi:  10.1186/s13054-022-04143-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 192. Braz de Oliveira MP, Moreira Padovez RFC, Serrão P, de Noronha MA, Cezar NOC, Andrade LP. Effectiveness of physical exercise at improving functional capacity in older adults living with Alzheimer's disease: a systematic review of randomized controlled trials. Disabil Rehabil. (2023) 45:391–402. doi:  10.1080/09638288.2022.2037744 [DOI] [PubMed] [Google Scholar]
  • 193. Savikangas T, Suominen TH, Alén M, Rantalainen T, Sipilä S. Changes in femoral neck bone mineral density and structural strength during a 12-month multicomponent exercise intervention among older adults - Does accelerometer-measured physical activity matter? Bone. (2024) 178:116951. doi:  10.1016/j.bone.2023.116951 [DOI] [PubMed] [Google Scholar]
  • 194. Meeusen R. Exercise, nutrition and the brain. Sports Med. (2014) 44 Suppl 1:S47–56. doi:  10.1007/s40279-014-0150-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 195. Zhao Z, Yan K, Guan Q, Guo Q, Zhao C. Mechanism and physical activities in bone-skeletal muscle crosstalk. Front Endocrinol (Lausanne). (2023) 14:1287972. doi:  10.3389/fendo.2023.1287972 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196. Lee BC, Kim KI, Cho KH, Moon CW. Effects of resistance training and nutritional support on osteosarcopenia in older, community-dwelling postmenopausal Korean females (ERTO-K study): a study protocol. BMC Geriatr. (2024) 24:68. doi:  10.1186/s12877-024-04667-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 197. Dietch DM, Kerr-Gaffney J, Hockey M, Marx W, Ruusunen A, Young AH, et al. Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: systematic review and implications for clinical practice. BJPsych Open. (2023) 9:e70. doi:  10.1192/bjo.2023.36 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 198. Lau K, Patel S, Rogers K, Smith S, Riba M. Cancer-related lymphedema and psychological distress. Curr Psychiatry Rep. (2024) 26:635–42. doi:  10.1007/s11920-024-01543-y [DOI] [PubMed] [Google Scholar]
  • 199. Pezzolato M, Spada G, Fragale E, Cutica I, Masiero M, Marzorati C, et al. Predictive models of psychological distress, quality of life, and adherence to medication in breast cancer patients: A scoping review. Patient Prefer Adherence. (2023) 17:3461–73. doi:  10.2147/ppa.S440148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 200. Amano K, Hopkinson J, Baracos V. Psychological symptoms of illness and emotional distress in advanced cancer cachexia. Curr Opin Clin Nutr Metab Care. (2022) 25:167–72. doi:  10.1097/mco.0000000000000815 [DOI] [PubMed] [Google Scholar]
  • 201. Azizoddin DR, DeForge SM, Zhao J, Chen M, Smith K, Schreiber KL, et al. Pilot testing of a multicomponent cancer pain-cognitive behavioral therapy mHealth app for patients with advanced cancer. JCO Clin Cancer Inform. (2025) 9:e2500228. doi:  10.1200/cci-25-00228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 202. Wagner LI, Tooze JA, Hall DL, Levine BJ, Beaumont J, Duffecy J, et al. Targeted eHealth intervention to reduce breast cancer survivors' fear of recurrence: Results from the FoRtitude randomized trial. J Natl Cancer Inst. (2021) 113:1495–505. doi:  10.1093/jnci/djab100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 203. Tauber NM, O’Toole MS, Jensen AB, Butow PN, Thewes B, Elkjær E, et al. ConquerFear-group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors. Psychooncology. (2023) 32:1424–32. doi:  10.1002/pon.6193 [DOI] [PubMed] [Google Scholar]
  • 204. Bahçacı U, Atasavun Uysal S, Erdogan İyigün Z, Ordu Ç, Soybir GR, Ozmen V. Progressive relaxation training in patients with breast cancer receiving aromatase inhibitor therapy-randomized controlled trial. PloS One. (2024) 19:e0301020. doi:  10.1371/journal.pone.0301020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 205. Eggers C, Olliges E, Boeck S, Kruger S, Uhl W, Meissner K. Exploring pain, quality of life, and emotional well-being in patients with advanced pancreatic cancer practicing spiritual meditation: A pilot study. Schmerzen, Lebensqualität und emotionales Wohlbefinden von Patienten mit fortgeschrittenem Pankreaskarzinom unter spiritueller Meditation: Eine explorative Pilotstudie. Complement Med Res. (2023) 30:289–98. doi:  10.1159/000529865 [DOI] [PubMed] [Google Scholar]
  • 206. Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of cancer recurrence: A systematic review and meta-analysis. J Clin Oncol. (2019) 37:2899–915. doi:  10.1200/jco.19.00572 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 207. Greer JA, Applebaum AJ, Jacobsen JC, Temel JS, Jackson VA. Understanding and addressing the role of coping in palliative care for patients with advanced cancer. J Clin Oncol. (2020) 38:915–25. doi:  10.1200/jco.19.00013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 208. Liu Y, Shen Y, Pan Q, He H, Zou H, Huang Z, et al. Application of interdisciplinary collaborative hospice care for terminal geriatric cancer patients: a prospective randomized controlled study. Support Care Cancer. (2022) 30:3553–61. doi:  10.1007/s00520-022-06816-x [DOI] [PubMed] [Google Scholar]
  • 209. Danhauer SC, Rutherford CA, Hurt G, Gentry S, Lovato J, McQuellon RP. Providing psychosocial group support for young women with breast cancer: findings from a wellness-based community collaboration. J Psychosoc Oncol. (2007) 25:103–20. doi:  10.1300/J077v25n01_06 [DOI] [PubMed] [Google Scholar]
  • 210. Opsomer S, Lauwerier E, De Lepeleire J, Pype P. Resilience in advanced cancer caregiving. A systematic review and meta-synthesis. Palliat Med. (2022) 36:44–58. doi:  10.1177/02692163211057749 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 211. Mehnert A, Koranyi S, Philipp R, Scheffold K, Kriston L, Lehmann‐Laue A, et al. Efficacy of the Managing Cancer and Living Meaningfully (CALM) individual psychotherapy for patients with advanced cancer: A single-blind randomized controlled trial. Psychooncology. (2020) 29:1895–904. doi:  10.1002/pon.5521 [DOI] [PubMed] [Google Scholar]
  • 212. Flaig TW, Spiess PE, Abern M, An Y, Bangs R, Begovic J, et al. Bladder cancer, version 1.2026, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. (2026) 24:186–203. doi:  10.6004/jnccn.2026.0022 [DOI] [PubMed] [Google Scholar]
  • 213. Ueland V, Dysvik E, Rørtveit K, Furnes B. Homeworld/alienworld: a qualitative study about existential experiences after cancer treatment. Scand J Caring Sci. (2021) 35:701–9. doi:  10.1111/scs.12902 [DOI] [PubMed] [Google Scholar]
  • 214. Thomas RJ, Beatty AL, Beckie TM, Brewer LC, Brown TM, Forman DE, et al. Home-based cardiac rehabilitation: A scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol. (2019) 74:133–53. doi:  10.1016/j.jacc.2019.03.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 215. Valizadeh A, Asghari S, Abbaspoor S, Jafari A, Raeisi M, Pilehvar Y. Implantable smart hyperthermia nanofibers for cancer therapy: Challenges and opportunities. Wiley Interdiscip Rev Nanomed Nanobiotechnol. (2023) 15:e1909. doi:  10.1002/wnan.1909 [DOI] [PubMed] [Google Scholar]
  • 216. Low CA. Harnessing consumer smartphone and wearable sensors for clinical cancer research. NPJ Digit Med. (2020) 3:140. doi:  10.1038/s41746-020-00351-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 217. Gresham G, Hendifar AE, Spiegel B, Neeman E, Tuli R, Rimel BJ, et al. Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients. NPJ Digit Med. (2018) 1:27. doi:  10.1038/s41746-018-0032-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 218. Menta AK, Subbiah IM, Subbiah V. Bringing wearable devices into oncology practice: fitting smart technology in the clinic. Discov Med. (2018) 26:261–70. [PubMed] [Google Scholar]
  • 219. Yang W, Du Y, Chen M, Li S, Zhang F, Yu P, et al. Effectiveness of home-based telerehabilitation interventions for dysphagia in patients with head and neck cancer: Systematic review. J Med Internet Res. (2023) 25:e47324. doi:  10.2196/47324 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 220. Park S, Hong J, Park D, Kim H, Yeon S, Lee K, et al. Designing an mHealth app for defecatory function rehabilitation of post-surgical colorectal cancer survivors. J Healthc Inform Res. (2026) 10:340–66. doi:  10.1007/s41666-026-00231-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 221. Mauriello A, Correra A, Maratea AC, Russo V, Liccardo B, Gragnano F, et al. The evolution of cardiac rehabilitation from supervised models to new frontiers in digital health. J Clin Med. (2026) 15(7):2515. doi:  10.3390/jcm15072515 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 222. Lauwereins L, D'Hoore A, Coeckelberghs E, Fieuws S, Vanderheyden H, Vandewalle E, et al. Development of S.Tool: An electronic diary for assessing bowel symptoms after rectal cancer surgery. Eur J Surg Oncol. (2026) 52:111755. doi:  10.1016/j.ejso.2026.111755 [DOI] [PubMed] [Google Scholar]
  • 223. Venkatesan M, Mohan H, Ryan JR, Schürch CM, Nolan GP, Frakes DH, et al. Virtual and augmented reality for biomedical applications. Cell Rep Med. (2021) 2:100348. doi:  10.1016/j.xcrm.2021.100348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 224. Su Z, Zhang L, Lian X, Guan M. Virtual reality-based exercise rehabilitation in cancer-related dysfunctions: Scoping review. J Med Internet Res. (2024) 26:e49312. doi:  10.2196/49312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 225. Sun P, Zhao Y, Men J, Ma Z, Jiang H, Liu C, et al. Application of virtual and augmented reality technology in hip surgery: Systematic review. J Med Internet Res. (2023) 25:e37599. doi:  10.2196/37599 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 226. Vásquez-Carrasco E, Sepúlveda-Ramirez M, Alegria Y, Benavides M, Hernandez-Martinez J, Fernández-Rodríguez E, et al. Effects of virtual reality-based cognitive training on cognitive function, instrumental activities of daily living, and depressive symptoms in older people with mild cognitive impairment: a systematic review with meta-analysis of randomized controlled trials. Front Neurol. (2026) 17:1728495. doi:  10.3389/fneur.2026.1728495 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 227. Zhou H, Zhang Y, Nie M, Ge L. Effects of virtual reality and robot-assisted therapy on rehabilitation outcomes in cerebral palsy: a systematic review and meta-analysis. J NeuroEng Rehabil. (2026) 23(1):168. doi:  10.1186/s12984-026-01973-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 228. Huang Q, Lin J, Han R, Peng C, Huang A. Using virtual reality exposure therapy in pain management: A systematic review and meta-analysis of randomized controlled trials. Value Health. (2022) 25:288–301. doi:  10.1016/j.jval.2021.04.1285 [DOI] [PubMed] [Google Scholar]
  • 229. Groninger H, Violanti D, Mete M. Virtual reality for pain management in hospitalized patients with cancer: A randomized controlled trial. Cancer. (2024) 130:2552–60. doi:  10.1002/cncr.35282 [DOI] [PubMed] [Google Scholar]
  • 230. Prelaj A, Miskovic V, Zanitti M, Trovo F, Genova C, Viscardi G, et al. Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review. Ann Oncol. (2024) 35:29–65. doi:  10.1016/j.annonc.2023.10.125 [DOI] [PubMed] [Google Scholar]
  • 231. Ikushima H, Watanabe K, Shinozaki-Ushiku A, Oda K, Kage H. A machine learning-based analysis of nationwide cancer comprehensive genomic profiling data across cancer types to identify features associated with recommendation of genome-matched therapy. ESMO Open. (2024) 9:103998. doi:  10.1016/j.esmoop.2024.103998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 232. Voigtlaender S, Pawelczyk J, Geiger M, Vaios EJ, Karschnia P, Cudkowicz M, et al. Artificial intelligence in neurology: opportunities, challenges, and policy implications. J Neurol. (2024) 271:2258–73. doi:  10.1007/s00415-024-12220-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 233. Morales-Osorio MA, Ordóñez-Vega R, Alomía Penafiel GA, Ordoñez-Mora LT. Effectiveness of tele-rehabilitation using AI-guided exercise and pain neuroscience education for fibromyalgia (FIBROIA): Protocol for a randomized controlled trial. PloS One. (2026) 21:e0349017. doi:  10.1371/journal.pone.0349017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 234. Zapaishchykova A, Zielke J, Tak D, Pardo JCC, Mojahed-Yazdi R, Soto-Rivera CL, et al. Artificial intelligence analysis of temporalis muscle thickness for monitoring sarcopenia and clinical outcomes in individuals with paediatric brain tumours: a retrospective cohort study. Lancet Digit Health. (2026), 100973. doi:  10.1016/j.landig.2025.100973 [DOI] [PubMed] [Google Scholar]
  • 235. Reddy AM, Kaur G, Ribaya VSD, Ribaya ELA, Reddy MC, Shah T, et al. Artificial intelligence and transforming cancer care. Discov Oncol. (2026). doi:  10.1007/s12672-026-05242-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 236. Zhang L, Liu S, Lan L, Zhang H, Luo X, Zhao D, et al. Concentration and Specialty Pair Patterns of Interdepartmental Consultations in Hospitalized Patients Using Real-World Data: Retrospective Cohort Study. J Med Internet Res. (2026) 28:e81670. doi:  10.2196/81670 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 237. Bland KA, Catalá-Vilaplana I, Nunez JJ, Capozzi LC, Campbell KL. Artificial intelligence meets cancer rehabilitation: Emerging evidence for exercise and physical activity interventions. Cancer Control. (2026) 33:10732748261432280. doi:  10.1177/10732748261432280 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 238. Llorente CDM, de Vries S, Bor P, Veerhoek L, Van de Berg JW, Meijer R, et al. Physical activity trends as predictors of postoperative complications in oncology patients: A machine learning approach. Digit Health. (2025) 11:20552076251408520. doi:  10.1177/20552076251408520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 239. Agha RA, Mathew G, Rashid R, Kerwan A, Al-Jabir A, Sohrabi C, et al. Transparency In The reporting of Artificial INtelligence - the TITAN guideline. Premier J Sci. (2025) 10:100082. doi:  10.70389/PJS.100082 [DOI] [Google Scholar]
  • 240. Nalela P, Rao D, Rao P. Explainable AI for predicting mortality risk in metastatic cancer: Retrospective cohort study using the Memorial Sloan Kettering-metastatic dataset. JMIR Cancer. (2026) 12:e74196. doi:  10.2196/74196 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 241. Roy A, Bhoyar A, Ahirwar A, Pawade Y, Chandra N. Artificial intelligence in oncology: Current status and possibilities (review). Med Int (Lond). (2026) 6:20. doi:  10.3892/mi.2026.304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 242. Lukkahatai N, Han G, Benjasirisan C, Park J, Jia HM, Li M, et al. A comparison of in-person and telehealth personalized exercise programs for cancer survivors: A secondary data analysis. Cancers (Basel). (2025) 17(15):2432. doi:  10.3390/cancers17152432 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 243. Clinical Oncology Society of Australia . Position statement on exercise in cancer care. Med J Aust. (2019) 210:54–54.e1. doi:  10.5694/mja2.12039 [DOI] [PubMed] [Google Scholar]
  • 244. Chen Y, He Z, Wu Y, Bai X, Li Y, Yang W, et al. A wearable molecularly imprinted electrochemical sensor for cortisol stable monitoring in sweat. Biosens-Basel. (2025) 15(3):194. doi:  10.3390/bios15030194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 245. Min J, Tu J, Xu C, Lukas H, Shin S, Yang Y, et al. Skin-interfaced wearable sweat sensors for precision medicine. Chem Rev. (2023) 123:5049–138. doi:  10.1021/acs.chemrev.2c00823 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 246. Hao J, Li Y, Swanson R, Chen Z, Siu KC. Effects of virtual reality on physical, cognitive, and psychological outcomes in cancer rehabilitation: a systematic review and meta-analysis. Support Care Cancer. (2023) 31:112. doi:  10.1007/s00520-022-07568-4 [DOI] [PubMed] [Google Scholar]
  • 247. Chen Y, Chen X, Li L, Li Y, Yan Q, Hu X. The Efficacy of Virtual Reality-Based Interventions on Pain, Anxiety, Depression, and Quality of Life Among Patients With Cancer: A Meta-analysis of Randomized Controlled Trials. Cancer Nurs. (2026) 49(4):E302–14. doi:  10.1097/NCC.0000000000001430 [DOI] [PubMed] [Google Scholar]
  • 248. Hao J, Yao Z, Fan P, Remis A, Wu K. Artificial intelligence in cancer survivorship: evaluating ChatGPT's performance in rehabilitation-related queries. Support Care Cancer. (2026) 34(5):439. doi:  10.1007/s00520-026-10681-3 [DOI] [PubMed] [Google Scholar]
  • 249. Park S, Kim E, Youn J, Jung M, Park J, Nam KE, et al. Risk stratification strategies and implementation of exercise training in patients with multiple myeloma. Curr Oncol Rep. (2025) 27:1448–63. doi:  10.1007/s11912-025-01719-6 [DOI] [PubMed] [Google Scholar]
  • 250. Silva AMG, do Nascimento OV, Barros AMC, Acho LDR, Miranda CVS, Filho SA, et al. Safety evaluation of the aqueous extract of Fridericia chica (Bonpl.) L. G. Lohmann in rats subjected to swimming exercise. J Ethnopharmacol. (2025) 353:120293. doi:  10.1016/j.jep.2025.120293 [DOI] [PubMed] [Google Scholar]
  • 251. Zhang N, Cheng J, Wang S, Huang H. Impact of continuous care based on multidisciplinary collaboration on the quality of life of patients with colorectal cancer undergoing chemotherapy. Front Med (Lausanne). (2026) 13:1799635. doi:  10.3389/fmed.2026.1799635 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 252. Jia Y, Ma W, Zhao J, Niu Q, Zhang Q, Cui L. Intestinal rehabilitation plan for patients with colorectal cancer during the perioperative period: An evidence synthesis. J Multidiscip Healthc. (2026) 19:583146. doi:  10.2147/jmdh.S583146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 253. Latif A, Janabi NA, Joshi M, Bakri NAC, Kwasnicki RM, Fusari G, et al. Feedback from wearable devices accelerates recovery after breast cancer surgery. Eur J Surg Oncol. (2026) 52:111784. doi:  10.1016/j.ejso.2026.111784 [DOI] [PubMed] [Google Scholar]
  • 254. Wu T, Han T, Zhang X, Dai Y, Meng X. A telemedicine app for nonrigid facial rehabilitation training enhanced by efficient fully convolutional neural network with residual network (EffiFCNN-ResNet) to improve accessibility for patients with nasopharyngeal carcinoma cancer: Randomized controlled trial. JMIR Mhealth Uhealth. (2026) 14:e72560. doi:  10.2196/72560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 255. Liu C, Xue J, Wang T, Hou X, Chen D, Wang Y, et al. High-Dose Sunitinib Accelerates Triple-Negative Breast Cancer Metastasis by Modulating an Immunosuppressive Microenvironment: A Preclinical 4T1 Model Study. Pharm Res. (2026) 43(6):2025–39. doi:  10.1007/s11095-026-04124-1 [DOI] [PubMed] [Google Scholar]
  • 256. Liu J, Peng X, Yang Y, Huang X, Du Y, Liu K. A structured classification of pyrotinib-containing neoadjuvant regimens for HER2-positive breast cancer: Efficacy, safety, and regimen selection. Breast Cancer (Dove Med Press). (2026) 18:600575. doi:  10.2147/bctt.S600575 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 257. Bernstein LJ, Catton PA, Tannock IF. Intra-individual variability in women with breast cancer. J Int Neuropsychol Soc. (2014) 20:380–90. doi:  10.1017/s1355617714000125 [DOI] [PubMed] [Google Scholar]
  • 258. de Andrade KC, Khincha PP, Hatton JN, Frone MN, Wegman-Ostrosky T, Mai PL, et al. Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: An observational cohort study. Lancet Oncol. (2021) 22:1787–98. doi:  10.1016/s1470-2045(21)00580-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 259. Wang M, Chen J, Wang C, He Y. Progress in the application of combined detection of urinary tumor DNA and exosomes in the classification, staging, and clinical management of bladder cancer: A review. Front Oncol. (2026) 16:1745178. doi:  10.3389/fonc.2026.1745178 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 260. Zhang L, Zi B, Hong J, Chen Y, Ju S, Jing R, et al. Identification of serum 5’tRF-Val as a promising non-invasive biomarker for early detection of esophageal cancer. Sci Rep. (2026). doi:  10.1038/s41598-026-54913-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 261. McNeish BL, Kunzer B, Bell SG, Rosano C. The association of thigh myosteatosis with lower cognitive function in older cancer survivors. GeroScience. (2026) 48(3):3703–13. doi:  10.1007/s11357-025-01857-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 262. Brick R, Jensen‐Battaglia M, Streck BP, Page L, Tylock R, Cacciatore J, et al. Exploring geriatric assessment-driven rehabilitation referral patterns and its influence on functional outcomes and survival in older adults with advanced cancer. J Am Geriatr Soc. (2025) 73:136–49. doi:  10.1111/jgs.19250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 263. Choi E, Pierce J, Xu Y, Wu D, Wong‐Meli CCY, Wang C, et al. Moderating effects of social determinants of health on quality of life in expressive writing interventions among Chinese American breast cancer survivors. Psychooncology. (2026) 35:e70511. doi:  10.1002/pon.70511 [DOI] [PubMed] [Google Scholar]
  • 264. Luo T, Xue M, Du Y, Chen H, Sun Y, Sun H. Integrative multi-omics and network analysis identify potential targets of Chaihu Shugan Xiaozheng Formula in breast cancer. Transl Oncol. (2026) 70:102829. doi:  10.1016/j.tranon.2026.102829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 265. Eghtedar S, Jasemi M, Habibzadeh H. The role of beliefs and psychological factors in caring of patients with cancer: The lived experiences of informal caregivers. Holist Nurs Pract. (2021) 35:248–56. doi:  10.1097/hnp.0000000000000468 [DOI] [PubMed] [Google Scholar]
  • 266. Grassi L. Psychiatric and psychosocial implications in cancer care: The agenda of psycho-oncology. Epidemiol Psychiatr Sci. (2020) 29:e89. doi:  10.1017/s2045796019000829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 267. Dev R, Kadakia KC, Tennison JM, Amano K, Szafranski M, Bruera E, et al. Nutrition rehabilitation programs and cachexia clinics for anorexia-cachexia syndrome in patients with cancer. Oncologist. (2026) 31(3):oyag042. doi:  10.1093/oncolo/oyag042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 268. Davidoff C, Cheville A. Telemedicine in cancer rehabilitation: Applications and opportunities across the cancer care continuum. Am J Phys Med Rehabil. (2024) 103:S52–s57. doi:  10.1097/phm.0000000000002421 [DOI] [PubMed] [Google Scholar]
  • 269. Oneda E, Noventa S, Libertini M, Cherri S, Manno A, Meriggi F, et al. Training gut and body: Physical activity, diet, ASA and microbiota influence the outcome in gastrointestinal cancer survivors. Front Nutr. (2025) 12:1648004. doi:  10.3389/fnut.2025.1648004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 270. Eldemery NI, Hashad RE, Salama HA, Elkest HRA, Mejia EJ, Senosy AMK, et al. The effect of applying eye movement exercise on pain and sleep quality among children undergoing chemotherapy. BMC Nurs. (2026) 25(1):465. doi:  10.1186/s12912-026-04750-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 271. Kondylakis H, Axenie C, Bastola D, Katehakis DG, Kouroubali A, Kurz D, et al. Status and recommendations of technological and data-driven innovations in cancer care: Focus group study. J Med Internet Res. (2020) 22:e22034. doi:  10.2196/22034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 272. Chemmami A, Guezouli L, Houasnia AA, Djenfi N, Merzoug MA, Outtas M, et al. AI-guided inflatable neck brace for personalized cervical support. Sensors (Basel). (2026) 26(10):2928. doi:  10.3390/s26102928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 273. Arogyasami D. RareCure: An open-source artificial intelligence pipeline for context-adaptive treatment discovery in rare solid tumors. Cureus. (2026) 18:e109744. doi:  10.7759/cureus.109744 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 274. Min J, Sempionatto JR, Teymourian H, Wang J, Gao W. Wearable electrochemical biosensors in North America. Biosens Bioelectron. (2021) 172:112750. doi:  10.1016/j.bios.2020.112750 [DOI] [PubMed] [Google Scholar]
  • 275. Ray TR, Choi J, Bandodkar AJ, Krishnan S, Gutruf P, Tian L, et al. Bio-integrated wearable systems: A comprehensive review. Chem Rev. (2019) 119:5461–533. doi:  10.1021/acs.chemrev.8b00573 [DOI] [PubMed] [Google Scholar]
  • 276. Sempionatto JR, Lasalde-Ramírez JA, Mahato K, Wang J, Gao W. Wearable chemical sensors for biomarker discovery in the omics era. Nat Rev Chem. (2022) 6:899–915. doi:  10.1038/s41570-022-00439-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 277. Papachristou N, Kotronoulas G, Dikaios N, Allison SJ, Eleftherochorinou H, Rai T, et al. Digital transformation of cancer care in the era of big data, artificial intelligence and data-driven interventions: Navigating the field. Semin Oncol Nurs. (2023) 39:151433. doi:  10.1016/j.soncn.2023.151433 [DOI] [PubMed] [Google Scholar]
  • 278. Esteva A, Robicquet A, Ramsundar B, Kuleshov V, DePristo M, Chou K, et al. A guide to deep learning in healthcare. Nat Med. (2019) 25:24–9. doi:  10.1038/s41591-018-0316-z [DOI] [PubMed] [Google Scholar]
  • 279. Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S, et al. Artificial intelligence in healthcare: Past, present and future. Stroke Vasc Neurol. (2017) 2:230–43. doi:  10.1136/svn-2017-000101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 280. Topol EJ. High-performance medicine: The convergence of human and artificial intelligence. Nat Med. (2019) 25:44–56. doi:  10.1038/s41591-018-0300-7 [DOI] [PubMed] [Google Scholar]
  • 281. Bangla S, Kapoor A, Jeer G. Toward equitable digital health: an integrated framework addressing exclusion, ethics, and implementation across healthcare systems. Int J Equity Health. (2026). doi:  10.1186/s12939-026-02903-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 282. Armstrong M. Modernisation of chronic respiratory disease management: The integration of wearable technology. Chron Respir Dis. (2026) 23:14799731261454686. doi:  10.1177/14799731261454686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 283. Sim J, Kim D, Yoo SH, Cho W, Hwang IY, Lee SY, et al. Social capital and financial toxicity in caregivers of patients with advanced cancer: Associations with health-related quality of life and psychological distress. J Natl Compr Canc Netw. (2026) 24:155–62. doi:  10.6004/jnccn.2025.7141 [DOI] [PubMed] [Google Scholar]
  • 284. Derry‐Vick H, Khoudary A, Billini O, Prigerson HG, Schwartz MD, Cohen J, et al. Stress management program for scanxiety in people with advanced lung cancer: Intervention adaptation and stakeholder feedback. Psychooncology. (2025) 34:e70048. doi:  10.1002/pon.70048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 285. Shigemoto K, Abe K, Kaneko F, Okamura H. Assessment of degree of satisfaction of cancer patients and their families with rehabilitation and factors associated with it--results of a Japanese population. Disabil Rehabil. (2007) 29:437–44. doi:  10.1080/09638280600835952 [DOI] [PubMed] [Google Scholar]
  • 286. Miller LJ, Postavaru G, Rowlands G, Prior M, Webb Z, Wragg A, et al. Cultural and linguistic adaptation and validation of a nutrition literacy instrument for use in people with cancer in the United Kingdom. J Hum Nutr Diet. (2026) 39:e70218. doi:  10.1111/jhn.70218 [DOI] [PubMed] [Google Scholar]
  • 287. Gao Z, Li S, Xu Y, Zhang M, Wang J, Bai X. Health-promoting lifestyle and associated factors among head and neck cancer patients in Northeast China: A cross-sectional study. J Adv Nurs. (2026) 82:2959–75. doi:  10.1111/jan.17102 [DOI] [PubMed] [Google Scholar]
  • 288. Jurys T, Kupilas A, Rajwa P, Bryniarski P, Burzyński B. Role of preoperative patient education among prostate cancer patients treated by radical prostatectomy. Cent Eur J Urol. (2022) 75:272–6. doi:  10.5173/ceju.2022.0037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 289. Kopec M, Quartey NK, Snow M, Stechkevich A, Giuliani ME, Papadakos J. Improving access to patient education: An audit of extant educational materials. J Cancer Educ. (2023) 38:885–94. doi:  10.1007/s13187-022-02202-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 290. Lange-Drenth L, Schulz H, Endsin G, Bleich C. Association of the extent of internet use by patients with cancer with social support among patients and change in patient-reported treatment outcomes during inpatient rehabilitation: Cross-sectional and longitudinal study. JMIR Cancer. (2023) 9:e39246. doi:  10.2196/39246 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 291. Tang XY, Wei YX, Kong LN, Lu F. Relationship between social support and self-care ability among patients with breast cancer during rehabilitation: The multiple mediating roles of resilience and depression. J Clin Nurs. (2025) 34:161–70. doi:  10.1111/jocn.17290 [DOI] [PubMed] [Google Scholar]
  • 292. Alkhafaji AH, Alkhafaji H, Alabsi M, Alarasi M, Al-Jamei S. Screen-detected cognitive impairment, psychological distress, and quality of life in cancer patients undergoing chemotherapy in Yemen. BMC Psychol. (2026). doi:  10.1186/s40359-026-04863-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 293. Tsai JJ, Wu CJ, Hu HF, Wang YJ. Symptom severity subgroups and individual symptom-associated risk for fear of progression in metastatic breast cancer. Oncol Nurs Forum. (2026) 53:1–9. doi:  10.1188/26.ONF.e26535304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 294. Encarnación JA, Macías VM, Muñoz IDLF, Soria VD, Fornos LF, Antequera MA, et al. Apalutamide and stereotactic body radiotherapy in metastatic hormone-sensitive prostate cancer: Multicenter real-world study. Cancers (Basel). (2025) 17(13):2216. doi:  10.3390/cancers17132216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 295. Gouliaev A, Szejniuk WM, Fledelius J, Madsen HHT, Petersen RH, Rasmussen TR. Discrepancies in regional lung cancer multidisciplinary team decisions can be reduced through national consensus meetings. Acta Oncol. (2025) 64:793–6. doi:  10.2340/1651-226x.2025.43314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 296. Miszczyk M, Bilski M, Kói T, Konat-Bąska K, Suleja A, Fazekas T, et al. Metastasis-directed therapy in the management of urothelial carcinoma: A systematic review and meta-analysis. Eur Urol Focus. (2025) 11:638–47. doi:  10.1016/j.euf.2025.03.011 [DOI] [PubMed] [Google Scholar]
  • 297. Vieillard MH, Thureau S. Multidisciplinary meetings dedicated to bone metastases: A historical perspective and rationale. Bull Cancer. (2013) 100:1135–9. doi:  10.1684/bdc.2013.1851 [DOI] [PubMed] [Google Scholar]
  • 298. Mori M, Kikuchi M, Miyabe R, Kita H, Kobayashi J, Atsuta K, et al. A case requiring differential diagnosis of synovitis, acne, pustulosis, hyperostosis, osteomyelitis syndrome in the evaluation of bone lesions in early breast cancer. Surg Case Rep. (2026) 12(1):25–0822. doi:  10.70352/scrj.cr.25-0822 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 299. Shallwani SM, Thomas R, King J, Toupin-April K, Poitras S. Perspectives and experiences of leisure-time physical activity in adults with stage 4 cancer: A qualitative interpretive-description study. Disabil Rehabil. (2024) 46:1515–26. doi:  10.1080/09638288.2023.2200037 [DOI] [PubMed] [Google Scholar]
  • 300. Wang W, Lu Z, Posum W, Qian Y, Liu H, Jiang K, et al. Situs inversus totalis and lung cancer: A case report of surgical resection after neoadjuvant chemoimmunotherapy for stage IIIB squamous cell carcinoma. Front Oncol. (2026) 16:1756152. doi:  10.3389/fonc.2026.1756152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 301. Guo Z, Han X, Chen J, Zhang L, Sun J, Li Q, et al. Recent advances and treatment strategies in liver metastasis of pancreatic neuroendocrine tumors. Cancer Metastasis Rev. (2025) 44:85. doi:  10.1007/s10555-025-10303-0 [DOI] [PubMed] [Google Scholar]
  • 302. Heywood R, McCarthy AL, Skinner TL. Safety and feasibility of exercise interventions in patients with advanced cancer: a systematic review. Support Care Cancer. (2017) 25:3031–50. doi:  10.1007/s00520-017-3827-0 [DOI] [PubMed] [Google Scholar]
  • 303. Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. (2012) 2012:Cd007566. doi:  10.1002/14651858.CD007566.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 304. Galvão DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol. (2005) 23:899–909. doi:  10.1200/jco.2005.06.085 [DOI] [PubMed] [Google Scholar]
  • 305. Buffart LM, Kenkhuis M, Newton RU, May AM, Galvão DA, Courneya KS, et al. Targeting exercise interventions to patients with cancer in need: an individual patient data meta-analysis. J Natl Cancer Inst. (2018) 110:1190–200. doi:  10.1093/jnci/djy161 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES